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ABSTRACT

The use of ionizing radiation within medicine creates an interesting paradox.
First, x-rays can be used as an excellent diagnostic tool, allowing doctors to view internal
biological structures without having to perform surgery. This can be done thanks to the
characteristics of high energy photons, namely excellent penetration depth and various
levels of absorption based upon the density of a material. These same characteristics
make ionizing radiation a very effective treatment method for cancer. Radiation focused
on a tumor will deposit energy when it interacts with a biological structure (e.g. DNA),
eventually causing enough damage to kill the cell. That same damage can be done to
healthy cells and tissue, slowing the natural healing and repair response of the body.
Adipose derived stem cells (ADSCs) are a mesenchymal stem cell line that has
been proven to have similar characteristics to bone marrow derived stem cells, except that
they much easier to obtain. Within the body, ADSCs act as immunomodulators and assist
with the maintenance and repair of tissues. They have been shown to have excellent
differentiation capability, making them an extremely viable option for stem cell therapies
and regenerative medicine applications.
Due to the tissue ADSCs are derived from, they are highly likely to be affected by
radiation therapy, especially when treating something like breast cancer. For this reason,
the purpose behind this research is to better understand how ADSCs are affected by doses
of radiation similar to a single fraction of radiation therapy. We will also explore
different dose rates to determine if there is a significant difference in the response of
ADSCs. Finally, a method for researching ultra-low doses of radiation will be developed,
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allowing experimental doses closer to what is experienced from a diagnostic imaging
procedure like computed tomography to be performed.
The results shown from this research will help fill in the gap regarding how
ADSCs respond to radiation therapy relevant doses of ionizing radiation. The potential
ADSCs have in the space of regenerative medicine makes them an ideal candidate for
study with ionizing radiation, as they are one of the main cell types to promote tissue
healing.
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CHAPTER ONE
INTRODUCTION

1.1. Motivation
Ionizing radiation is a powerful tool in medicine, capable of providing doctors
with images of internal organs and metabolic processes to killing tumors. The various
methods of generating ionizing radiation make it possible to have such a wide array of
applications. However, it is not currently possible to focus radiation perfectly on an area
of interest without exposing some healthy tissue. Treatment plans minimize the exposure
of healthy tissue as much as possible, but the current limitations of imaging and cancer
treatment will always cause some exposure of healthy tissue.
Adipose tissue surrounds most organs to a degree and is present all around the
body, making it highly likely to be affected by radiation treatment. Stem cells derived
from adipose tissue have been determined to be mesenchymal in nature with similar
properties to bone marrow derived stem cells making them a viable source for tissue
engineering and regenerative medicine. Treating cancers that are found near high
amounts of adipose tissue, such as breast cancer, has a high likelihood of affecting these
adipose derived stem cells (ADSCs).
ADSC were discovered relatively recently, and the ease with which they can be
obtained has made them a popular cell type for many areas of research. Within radiation
research, they are an understudied cell type, and given their potential, this gap needs to be
addressed. The overarching goal of this research is to determine how ADSCs respond to
doses of ionizing radiation relevant to cancer therapy, and to build a foundation on which
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ultra-low dose radiation research can be performed in order to explore dose levels closer
to images sources.

1.2. Research Aims
1.2.1. Aim 1: Adipose Stem Cell Proliferation After Gamma Irradiation
The purpose of this aim is to set a baseline understanding for how ADSCs react to
various doses of gamma radiation that are similar to what a patient might receive from a
single fractionated dose during cancer therapy. Since ADSCs has not been studied
extensively in relation to radiation, it is important to first understand how radiation
affects the growth cycle. This will be done by using various molecular biology techniques
to study proliferation rate and changes in specific cell cycle stage populations.
1.2.2. Aim 2: The Effect of Very Low Dose X-Ray Radiation on Fibroblasts
Radiation exposure to patients during imaging procedures is significantly lower
than during cancer therapy. It was long assumed that radiation affected cells and tissues
in a linear manner (Linear No Threshold model), meaning that all radiation is bad and
carries a certain amount risk. More recently it has been shown that this model is
incorrect, with lower doses of radiation not causing the effect predicted. This aim will try
to address some inconsistencies with ultra-low dose radiation by using a well
characterized, custom x-ray radiation source and a well-known cell type, 3t3 fibroblasts.
Cells will be tested for changes in proliferation, total protein content, cell cycle arrest,
and stained for collagen type-I production.
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1.2.3. Aim 3: Changes in Ionizing Dose Rate Affect Cell Cycle Progression in
Adipose Stem Cells
The rate at which cells receive ionizing radiation has been hypothesized to affect
their response. Depending on the type of source being used, the dose rate can fluctuate
quite a lot, requiring patients to be in treatment for longer or shorter periods of time to
receive the same total dose. Here, ADSCs will be irradiated to the same total dose using 2
different dose rates to determine the impact on cell health and growth. ADSCs will be
checked for changes proliferation rate, induction of apoptosis, cell cycle arrest, changes
in cell cycle regulation proteins p53 and p21, and the occurrence of senescence.

1.3. Document Outline
The content of each chapter will be laid out as follows. Chapter 2 will present the
background and a review of the literature pertinent to the aims listed above. Chapter 3
will present the calibration method used to create a radiation source characterization
protocol and confirm the dose given by the gamma source at Wake Forest. Chapter 4 will
present the research fulfilling Aim 1 where ADSCs were exposed to various total doses
of radiation to determine the changes in growth response. Chapter 5 will present the
research fulfilling Aim 2 where an ultra-low dose x-ray system was developed in order to
test doses of radiation relevant to medical imaging. Chapter 6 will present the research
fulfilling Aim 3 where the total dose of radiation given to ADSCs was kept constant
while the dose rate was changed. Chapter 7 will present the overall conclusions of this
research and layout suggestions for future work.
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CHAPTER TWO
LITERATURE REVIEW

2.1 Introduction
The long-term health effects of low-dose complex radiation are still largely not
understood. Literature on the specific cellular effects of radiation is inconsistent as the
cell types, radiation dose and quality, dose rate, and culture environment vary
significantly between studies. As with materials, one cell type may react very differently
than another cell type to a specific form of radiation. If radiation is focused on a specific
area of the body, as it is in most cancer treatments, the number of cell types affected is
significantly decreased, but the exposure of healthy cells is not completely eliminated.
The matter is complicated even further when stem cells enter the irradiated area. Since
stem cells are key for the recruitment of immune cells that help begin the repair process
to damaged tissue, as well as their ability to differentiate into multiple cell types, the way
they react to radiation will change over time as they differentiate to help repair the
affected area.

2.2 Stem Cells
The power of stem cells in medicine is dependent upon the cells’ capability to
differentiate into various other cell types. During early development, embryonic stem
cells are responsible for the creation of all cell types and tissues through
differentiation[1]. This totipotent ability is solely a characteristic of the embryonic stem
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cells present in a zygote, something that is lost as the organism fully develops. These
totipotent stem cells can be considered the “forbidden fruit” of the tissue engineering and
regenerative medicine field because of the ethical and moral boundaries that have to be
crossed in order to use them in research. Instead, it is much more common to use stem
cells that have been isolated from adults, and while adult stem cells no longer have the
complete differentiation capacity of their embryonic progenitors, if taken from the right
tissue source, adult stem cells can still have multipotent differentiation capabilities.
Adult stem cells are found throughout the body and help maintain healthy tissues
and repair damage after injury or disease. In normal physiology, these cells assist in the
repair and maintenance of tissues and can function as immunomodulators, secreting
cytokines to decrease inflammation[2–4]. Without this modulation at an injury sites,
healing would take much longer, potentially turning minor incidences into much more
major situations. In biomedical research, adult mesenchymal stem cells (MSCs) are
frequently used as an in vitro model due to the relative ease with which they can be
obtained and their multipotent differentiation capability[4–6]. The most commonly used
MSCs are bone marrow-derived and adipose-derived stem cells, which have both been
shown to be viable sources of adult stem cells by many sources[2,3,6,7].
Adipose-derived stem cells (ADSCs) were first discovered in 2001 by Zuk et al at
UCLA as processed lipoaspirate cells, but were proposed to be stem cells. This same
team followed up within a year proving that the cells they found were indeed stem cells
and at the same time, confirming two important facts: the differentiation capacity and
clonogenicity of the cells[8]. These two characteristics define a stem cell because it
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means they have the potential to differentiate into multiple cell lineages from a single
cell. Research in the following years confirmed and built upon the potential of these cells.
The most surprising part of this discovery is that ADSCs have been shown to have the
potential to differentiate into the ectodermal (neuronal-like cells[9]) and endodermal
(hepatocytes[10]) lineages, an ability that to our knowledge, only embryonic stem cells
possessed.

Figure 2.1: Stem cell differentiation
based upon substrate stiffness[12].

Much research has been done to determine the mechanical cues it takes to cause
differentiation of ADSCs. This is very important as the chemical cues sometimes used to
cause differentiation in vitro are not viable options for an in vivo study. At that point,
only the mechanical properties of the surrounding tissue and whatever chemical cues the
native cells release can cause stem cell differentiation. Frequently, the mechanical cues
being given to cultured cells consist of substrates with varied stiffness[11,12], though
depending on the desired differentiation, some form of mechanical loading can be
necessary[13–15]. Seen in Figure 1, cells plated on polyacrylamide gels with different
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stiffness can be seen to change morphology over a period of 96 hours. The matrix
dependent morphology change was done with standard growth media, taking away
chemical cues that would bias the differentiation pathway the cells began down. In order
to further verify the importance of substrate elasticity over chemical stimulation, Engler
et al added induction media to MSCs cultured on substrates with varied elasticity. If
induction media was added to the cells after only a week of culture on their specific
stiffness, the MSCs would falsely express factors for the cell type of the induction media,
creating a “mixed phenotype” MSC; however, if cells were allowed to grow for a period
of 3 weeks before induction media was added, the cells were more committed to their
differentiation pathway and minimally expressed factors from the induction media[12].
Mechanical stimulation could be argued to be the most important factor in the stimulation
of differentiation of MSCs, especially for cell types like neurons, osteoblasts,
chondrocytes, and myoblasts. Appropriate substrate elasticity of these cell types enhances
cell growth and can influence differentiation down specific pathways[12,16,17].
These characteristics are what make stem cells such an exciting experimental
subject for tissue engineering and regenerative medicine. Likewise, the ease with which
adipose-derived stem cells can differentiate into certain lineages compared with other
stem cell sources[7], coupled with the higher availability and ease of retrieval[4] makes
them an ideal candidate for most regenerative medicine applications going forward.
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2.3 Medical Radiation Types and Sources
Within medicine, different forms of radiation have been used to provide treatment
since the discovery of x-rays in 1895 by Wilhelm Röntgen. Due to the publication of his
findings, Edwin Frost took one of the first medical x-ray images of the broken wrist of
Eddie McCarthy[18], allowing doctors to make a diagnosis and plan treatment before
putting the patient through surgery. At this time, the dangers of x-ray radiation were
unknown, which led to many reports of hair loss and burns[18,19], and eventually death
from carcinomas[19] that more than likely were caused by overexposure. X-rays continue
to be used in medicine today for procedures ranging from diagnostic imaging to palliative
therapy to radiation therapy, although the dosage received by patients and doctors is
significantly more regulated.
2.3.1 Medical Imaging
The most common method x-rays are used in medicine today is in diagnostic
imaging, which can range from a simple x-ray image of the extremities, limbs, and teeth,
to more complex, full body “slices” obtained from computed tomography (CT) scans. As
seen in Figure 2, an x-ray source is rotated around the patient with an array of detectors
directly opposite, which can produce an image that is representative of a slice of the
body[20]. Sometimes the source will move axially while imaging (or the table the patient
is on will move), creating a helical pattern. It is possible to stitch all those individual
images together to create a 3-dimensional model of the imaged area. When used in
combination with other diagnostic techniques, the information gathered can be incredibly
powerful.
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Figure 2.2: CT schematic (www.fda.gov).

It is estimated that there were at least 77 million CT scans given in the United
States in 2014, a number that continues to rise as advances in the technology are
made[21–23]. The continued rise can be extrapolated from data showing the meteoric rise
in CT use from 1980 to 2005. Over this 2 decade time period, CT examinations in the
United States increased by a factor of 20[24], and while this rate certainly will not
continue, the power of CT examinations in diagnostic imaging continues to increase,
calling for more to be requested by physicians. The large increase in use has prompted
concern over the amount of radiation the general population is being exposed to[25].
Table 1 gives an abbreviated look at the amount of radiation a patient can expect to
receive during a specific procedure. Many of these procedures give radiation that is many
times the background rate, and even though the total dose is considered low, it is still
significantly elevated above what a non-patient receives just from background.
Positron emission tomography (PET) is another form of medical imaging that
makes use of ionizing radiation to form images. In this case, images are formed from
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very specific radionuclides that decay by positron emission[26,27]. Within the body, the
positron travels until it either loses all its energy or it interacts with an electron in tissue
and annihilates. The annihilation reaction produces a very specific pair of anti-parallel
511 keV gamma rays (Figure 3). If both gamma rays are able to be detected, the position
of the annihilation can be determined, allowing an image to be formed based upon the
positions of all the annihilations over a given period of time[27]. The power and
functionality of PET comes from the ability to tag naturally occurring biological
molecules or specific synthesized compounds with these positron emitting radionuclides.
These molecules will cluster at specific points in the body where their use or uptake is
high allowing specific biological processes to be tracked over time[26].

For this procedure:
Abdominal
Computed Tomography (CT) – Abdomen and Pelvis
Computed Tomography (CT) – Colonography
Radiography (X-ray) – Lower GI Tract
Radiography (X-ray) – Upper GI Tract
Bone
Radiography (X-ray) – Spine
Radiography (X-ray) – Extremity
Central Nervous System
Computed Tomography (CT) – Head
Computed Tomography (CT) – Spine
Chest
Computed Tomography (CT) – Chest
Radiography – Chest
Dental
Intraoral X-ray

An adult’s
approximate effective
radiation dose

Comparable to
natural background
radiation

10 mSv
6 mSv
8 mSv
6 mSv

3 years
2 years
3 years
2 years

1.5 mSv
0.001 mSv

6 months
3 hours

2 mSv
6 mSv

8 months
2 years

7 mSv
0.1 mSv

2 years
10 days

0.005 mSv

1 day

Table 2.1: A selected look at the effective dose received by a patient for a single procedure. The dose given is
compared to natural background radiation by providing the amount of time required to receive that dose naturally.
This chart has been modified from the source, which can be found here
(http://www.radiologyinfo.org/en/info.cfm?pg=safety-xray).
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Figure 2.3: The process of β decay resulting in positron emission. The emitted
positron loses energy as it travels through tissue until it interacts with an electron,
causing annihilation and subsequent gamma ray emission
(http://depts.washington.edu/nucmed/IRL/pet_intro/intro_src/fig1_small.JPG).

Similar to CT scans, the radiation dose a patient receives from a PET scan is
dependent upon the location of the scan. The specific radionuclide used also has an
impact as the half-lives vary, which is important depending on the biological process
being observed[27]. One of the commonly used radionuclides, 18F has a half-life of 110
minutes, making it ideal for viewing many different processes. For a single full body
scan, the highest doses observed were in the gonads (5.0 mSv), uterus (7.8 mSv), and
bladder (59.2 mSv), with all other organs receiving lower doses[28]. The high dose seen
in the bladder is a result of accumulation before being expelled from the body. Compared
to full body CT scans, the dose received from a PET scan is lower. However, PET scans
are rarely performed as a standalone test, frequently being paired with a CT scan that’s
done simultaneously. While the diagnostic data received from this combination of scans
is immensely powerful, the effective dose a patient receives from a single scan can range
between 13 mSv and 32 mSv for a full body scan[28].
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2.3.2

Radiation Therapy

The properties of ionizing radiation also make it a great use for therapeutic
procedures, such as palliative therapy, cancer therapy, and radiosurgery[29–31]. These
therapies make use of higher energy radiation than what is typically found in medical
imaging devices, making them more damaging to the biological material they interact
with. Gamma radiation is typically used for specialized treatments, such as radiosurgery,
due to its smaller wavelength and naturally higher energy than x-rays. This allows
gamma radiation to have better tissue penetration characteristics, and will deposit more
energy where the focal point is located. As seen in Figure 4, gamma rays and x-rays exist
in the small wavelength end of the electromagnetic spectrum. The boundary between xrays and gamma rays is difficult to distinguish due to their inherent properties as
electromagnetic waves. The best distinction between x-rays and gamma rays is
comparing the source they were produced from: gamma rays are generated from nuclear
decay, x-rays are generated from electrons. There isn’t a distinct energy or wavelength
cutoff where the two can be differentiated from each other. The typically larger energy
carried by gamma rays also means it takes more energy to create them, which means they
are used in a different manner when it comes to medicine. Certain imaging contrast
agents emit gamma rays as they decay (technetium-99m for example), which is actually
beneficial because the higher energy of the gamma ray allows it to penetrate tissue better,
so it retains more information when it reaches the detector outside the body[26].
Ionizing radiation is used to treat cancer and other diseases all over the body. The
type of disease or tumor and its location will determine the specific method used to
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administer radiation treatment. Most commonly, radiation is given using an external
source such as a linear accelerator which is positioned above the target area in order to
provide maximal coverage. The entire dose required to treat the target area is not given in
a single session (such a high dose would cause extreme detrimental effects to the patient),
it is given in fractions over the course of a couple weeks[29,32]. Occasionally the target
area will not allow for an external source to be used, instead requiring radioactive seeds
to be placed in or near the target site. This can be because of the location or the size of
the target[33], but it can also be because it is the best option available. Similar to
implanted radioactive seeds, there is a development of radiolabeled antibodies that can
target tumor cells directly, and when used in combination with immunotherapy sees a
significant increase in survival rate[30,34].

Figure 2.4: The range of the electromagnetic spectrum. Short wavelength electronmagnetic waves are
considered to be ionizing radiation, capable of damaging small molecules such as proteins and DNA
(http://www.columbia.edu/~vjd1/electromag_spectrum.htm).

Radiosurgery, such as the gamma knife, is a very specific use for gamma
radiation. This technique uses an array of gamma ray sources to treat conditions within
the brain, typically a type of tumor, but other diseases can be treated as well[35]. The
array is fixed to the patient’s skull so the tumor does not move relative to the focal point
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of the gamma rays. Thanks to the high energy of the gamma rays, full tissue penetration
can be achieved without damaging the healthy tissue the radiation has to pass through to
reach the focal point in the tumor[31,35].
2.3.3 Extraterrestrial Radiation
Radiation is also an extremely important factor to consider during space flight.
The earth’s atmosphere and magnetosphere protect us from most forms of cosmic
radiation, but when astronauts leave the protection of the atmosphere, like during a visit
to the International Space Station, they are exposed to new types of radiation. On top of
x-rays and gamma rays, cosmic radiation includes high charge, high energy particle
radiation, or HZE ion radiation, as well as high energy protons[36–38]. Due to their high
energy, these radiation types have incredible penetrating power, rendering current
shielding methods useless and increasing the risk for cancer formation. Despite their high
damage potential, the frequency at which they would affect an astronaut is actually quite
low, approximating to once a month[36] which gives the body plenty of time to take the
proper action to correct the damage[39]. This does not mean that we can ignore this type
of radiation, but it doesn’t necessarily have to be the primary concern in radiation
exposure models.
While all these different types of radiation are dangerous in their own regard,
typically a single dose will not cause long-term damage to the human body unless it is of
unusually high dose (>10Gy). The important factor to keep track of is dose rate,
especially if multiple exposures are expected like in radiation therapy and space
exploration. During radiation therapy for cancer treatment, patients typically will receive
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a 1 or 2Gy dose per visit over a couple of weeks, with a final total dose of approximately
60Gy[29]. If this dose was given to the patient in a single treatment, or even at a faster
rate (1 week), it would surely kill the patient. Part of the reason behind doing multiple
low dose treatments is that it gives the healthy cells and tissues time to repair and remove
any cells that might have become damaged[39]. Cancer cells proliferate at too high a rate
to effectively repair any damage before they divide, which effectively kills the cell in the
long run.

2.4 Measures of Radiation Effects on Cellular Function
Most prior work has focused on the effect of radiation of whole tissues as opposed
to individual cellular responses[40]. While these studies are important, they have not
clarified the complicated cellular interactions taking place, an understanding of which
would provide a key foundation for possible preventative therapies. It is well known that
high, single doses of radiation (>10Gy) can kill a cell, or even an organism relatively
quickly[38,41,42], but at lower doses, the effects are not as well understood. There is
even evidence of beneficial effects at extremely low doses, but still above background
radiation[39,40,43,44]. This kind of effect is termed “radiation hormesis”, which means
very basically that at low doses it has beneficial effects, but is harmful at higher doses.
This range appears to be between 5mGy and 200mGy[39,45], which is significantly
lower than therapeutic or space relevant doses of radiation; however, the benefits that
arise appear to be protective responses which can last up to a couple days. The protective
responses include preventing and repairing DNA damage, and removing damaged cells
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through induced apoptosis, terminal differentiation, and initiating immune responses. All
of these help maintain the healthy cells, ensuring that any damage is swiftly removed
before it can cause more harm. Coupled with these protective responses, cells enter an
induced cell cycle suspension after radiation exposure which could be interpreted as
giving the cell a chance to repair or be removed before dividing again[45–47]. This
induced suspension doesn’t last more than a couple days, at which point they continue
dividing as normal.
While the potential beneficial effects of extremely low dose photon radiation are a
great area of research, most of the concern around radiation lies in its harmful effects.
From acute effects like DNA mutation, burns, and radiation sickness, to increased long
term risks of cancer formation, and even death, radiation is not something to be taken
lightly, which is why so much research goes into understanding how these effects occur.
DNA damage is one of the more concerning harmful effects of radiation
exposure. When a beam of radiation (either photon or particle) passes through a cell or
tissue, it deposits energy as it interacts with the surrounding area. In terms of DNA, the
damage can come in a couple different forms: single strand breaks (SSBs), double strand
breaks (DSBs), and complex damage, which is a mixed grouping of SSBs and DSBs in a
small area[36,37]. Complex damage is uncommon after low energy radiation exposure
such as x-ray and gamma ray radiation, but it is more common in higher energy radiation
like cosmic HZE ion radiation and heavy element particle radiation. This type of damage
is more likely to induce a cancerous state in the affected cell, making it an important area
of focus in biological radiation studies[36]. The high energy nature of these particles
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means that when an interaction occurs, it is more likely that all the energy will be
deposited at that single point instead of being spread out through the entire tissue as it
passes through. Low energy radiation, while having excellent penetration abilities, does
not deposit energy very frequently, which is why imaging is such a great use for them.
Even still, low energy radiation can still cause damage, but that damage is usually only
the SSBs or DSBs that are easily repairable if the cell is given enough time[39].

Figure 2.5: The cell cycle is divided into 4 phases that represent
different stages of growth as the cell prepares to divide. Within
this cycle are 3 checkpoints that help regulate cell health and
ensure the cell is properly prepared for the next phase[52].

The effects of radiation on the cell cycle is apparent no matter the type of
radiation or the dose. The natural flow is disrupted due to the assault of radiation directly
on the cell, causing affected cells to stop at one of the checkpoints within the cell cycle
(Figure 5)[48–51]. These checkpoints are specifically designed to ensure that a healthy,
fully functioning cell progresses to the next phase. The G1 checkpoint is the first time the
cell is checked for DNA damage or anything else that would result in less than perfect,
identical daughter cells[52]. A cell leaving G1 becomes fully committed to dividing, so it
is necessary for the cell to be healthy (no DNA damage) and to have enough size and
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stored energy. From here, the cell will move into S phase where DNA replication will
begin.

Figure 2.6: The p53 pathway is vital to maintaining cell health,
monitoring incoming stress from various sources such as oxidative
stress, hypoxia, and DNA damage to name a few. Depending on the
stressor, the response of the p53 pathway will change leading to cell
cycle arrest, apoptosis, senescence, DNA repair, and even metabolism
adjustment[54].

The second checkpoint is located at the end of the G2 phase before the cell enter
mitosis. DNA is checked for damage and replication mistakes that may have occurred
during transcription[52]. Similar to the G1 checkpoint, if anything is amiss with the cell,
it will halt its progression in the cell cycle until the problem is fixed. Beyond this
checkpoint is mitosis, also referred to as M phase, which is the process of cell division. A
final checkpoint exists at the end of metaphase that checks for the attachment of spindle
fibers to each pair of sister chromatids. Any damage or mutations that made it through all
the checkpoints have now been passed to two new cells, potentially increasing the risk of
cancer formation within that tissue.
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Thankfully, the mechanisms used to detect cellular stress and DNA damage at
each checkpoint are quite robust. While there are families of kinases and proteins that
detect specific types of stress and damage, they all feed into the p53 pathway, ultimately
activating p53 and a specific downstream outcome (Figure 6)[53,54]. In response to
ionizing radiation, there are two different kinases that could be activated, depending upon
the type of radiation: the ataxia telangiectasia mutated (ATM) kinase in response to
gamma radiation, or the ataxia telangiectasia and Rad3-related (ATR) kinase in response
to UV radiation[53]. The way that these different types of radiation interact with a cell is
the main mechanism behind the activation of ATM or ATR. Gamma radiation inherently
carries more energy, and therefore has the potential to cause more damage, making DSBs
much more common[48,50,54]. UV radiation doesn’t carry as much energy, so even
though it can still ionize molecules it interacts with, it is most likely to cause SSBs,
activating ATR. When activated, ATM phosphorylates p53, activating downstream cell
cycle arrest and apoptosis mechanisms, such as p21[55]. Cell cycle arrest occurs at either
the G0/G1 or the G2/M checkpoint, where repair of the DNA is attempted if the damage
isn’t too severe. P21 is activated directly from p53, and that combination is thought to
play a key role inhibiting the G1/S phase transition[56]. Interestingly, not all cell types
seem to follow this compete pathway in response to ionizing radiation exposure.
Embryonic stem (ES) cells specifically, do not arrest in at the G0/G1 checkpoint, despite
upregulation of p53[57], instead arresting in G2 in order to repair damage. It’s been
shown that ES cells have a downregulation of p21 following irradiation, with posttranscriptional miRNA regulation the cause[58]. Since ES cells rapidly pass through the
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cell cycle, they have a characteristically short G1 phase during normal proliferation,
which is only lengthened during periods of differentiation[57–59]. After radiation
exposure, DNA repair is crucial, especially in stem cells due to their differentiation
potential. Due to the potential for spontaneous differentiation in G1 phase, ES cells
exposed to ionizing radiation will skip the G0/G1 checkpoint in order to avoid DNA
damage being passed along to a new line of cells.
Momcilovic et al demonstrated the entire pathway between gamma irradiation and
cell cycle arrest in human embryonic stem cells. They found high levels of ATM present
in cells up to 4 hours after radiation exposure, after which the expression declined but
remained raised above non-irradiated cell expression levels. P53 activation followed the
same trend with a rise in expression peaking about 4 hours after exposure, then declining.
Similar results were found by Limoli et al in rat neural precursor cells where a 2-fold
increase in p53 levels was seen 2 hours after irradiation, and a 4-fold increase was seen 6
hours after irradiation. There are numerous other studies that have observed similar
trends in various cell lines with slightly different doses and different radiation sources (xray, gamma, heavy ion)[60–63]. It can logically be determined from these results that
progression down the p53 pathway is very fast once damage is detected to the DNA.
Biologically, this makes sense as any damage can become lethal to a cell and its progeny
if left unchecked. Rapid activation of the pathway that halts the cell cycle is a natural
development for continued survival.
In the event DNA damage cannot be repaired, a cell will proceed through
apoptosis by way of a p53 modulated protease cascade involving the activation of

20

cytochrome c, caspase-9, and caspase-3. Cytochrome c is a mitochondrial protein that
normally assists with electron transport, but the activation of p53 can result in
cytochrome c being released into the cytosol followed by the activation of Apaf-1[64].
These signals belong to the intrinsic apoptosis pathway that is activated by way of DNA
damage. Activated Apaf-1 cleaves procaspase-9, leading to the activation of caspase-9,
which activates caspase-3 (Figure 7)[53,65]. Cell death in this manner does not harm
neighboring cells or cause tissue inflammation like during cell necrosis; instead, the cell
breaks down the DNA and alters cell membrane receptors in order to signal neighboring
cells and macrophages that it’s about to die[64]. The material from the dead cell will be
phagocytosed and recycled.

Figure 2.7: Apoptosis can be activated through 2 main
pathways, either intrinsic or extrinsic. The intrinsic pathway is
activated by DNA damage and the p53 protein. The extrinsic
pathway is activated by membrane receptors called death
receptors (http://blogs.scientificamerican.com/guestblog/files/2013/10/apoptosis-pathway.jpg).

The extrinsic apoptosis pathway is activated by transmembrane receptors called
death receptors[64,65]. These receptors are members of the tumor necrosis factor (TNF)
family that receive signals from outside the cell, as opposed to internal cell damage.
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Activation of these receptors causes the aggregation of procaspase-8 which will cleave
one another activating caspase-3 resulting in apoptosis[66].
As discussed above, radiation can cause damage to DNA in varying degrees
depending on the type, energy, and dose. Higher doses of photon radiation (x-rays and
gamma) produce a higher incidence of apoptosis in exposed cells, with >4Gy causing
significant cell death[51,63,67]. This is a predictable trend since cell cycle arrest is
controlled through the same pathway and also experiences a dose dependent increase.
Time dependent gene expression can also be observed and taken into account.
Immediately after low dose radiation exposure (<1Gy), genes associated with apoptosis
are upregulated until being suppressed approximately 48 hours after exposure[68].
During this period of time, the cell is under a high amount of stress and has activated
specific defense mechanisms in order to protect itself. At later time points (at least 48
hours after exposure), surviving cells show a significant increase in gene expression
related to DNA repair and mitosis, suggesting cell cycle arrest has been reversed[68].
There is some controversy currently regarding methods of reporting apoptotic
cells and dead cells. Since proteins such as p53, caspase-3, -9, and -8 are so prominent
and important to the apoptotic pathways, increased activation is often used to draw the
conclusion that the cells are as good as dead[69]. The reality is that a cell is not
technically dead until (1) plasma membrane integrity has been lost, (2) the cell has
fragmented into apoptotic bodies, and/or (3) apoptotic bodies has been phagocytosed by
neighboring cells[70,71]. These classifications are especially important in cancer and
radiation research where apoptosis can be a common occurrence, or even the goal.
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Caution and careful experimental design needs to be taken when studying apoptosis and
potential cell death.

2.5 A Comparison of Total Dose and Dose Rate
The various modalities within medicine that using ionizing radiation have
different methods of producing that radiation. Gamma knife radiosurgery requires the use
of radioactive decay from elements such as cobalt-60 and cesium-137 in order to generate
gamma rays. CT and x-ray imaging, and external beam radiation therapy make use of xrays which are generated from accelerated electrons interacting with a metal target (e.g.,
tungsten, molybdenum, copper, cobalt). The energy and dose of these x-rays is dependent
upon the amount of power put in and the metal target. Based upon these factors, it can be
seen that the rate at which radiation is emitted can vary. While this knowledge is known
and adjusted for by radiation physicists in order to reach the appropriate total dose, there
is minimal work exploring how various rates of exposure could impact biological
material. The total dose received by a target, by contrast, has been researched to great
extent. This is likely due to the fact that the thresholds for increased cancer risk are
reported as total dose, with the only mention of dose rate usually given in the context of
chronic exposure[40,72].
Total dose received is certainly an important measure, as high doses have been
closely linked with increased risk in cancer formation[73,74]. However, the amount of
time it takes to reach that total dose (i.e. the dose rate) is arguably just as important. As
Jin et al have reported, most genes responsible for cellular defense, growth, and repair
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reacted in a time-dependent manner to ionizing radiation exposure, regardless of the total
dose received[68]. While they did not test different dose rates, their findings still provide
clues as to how cells might react. Since many of the genes necessary for defense and
recovery are up or down regulated depending on the elapsed time after radiation
exposure, it can be assumed that a lower dose rate would allow more recovery time
compared to a higher dose rate. Tseng et al observed the effects of low (20-25cGy/hr) and
high (25-50cGy/min) dose rates on neural stem cells, finding that reactive oxygen species
(ROS) and reactive nitrogen species (RNS) were raised in the low dose rate groups, but
not in the high dose rate groups at early time points[45]. They also found that nitric oxide
(NO) levels for both dose rates were above control, with high dose rate having a larger
response at 24 hours. The measure of ROS/RNS and NO is important to help understand
the amount of stress a cell is experiencing and to predict how a cell might respond, but it
is not a direct measure of changes to gene expression, protein activation, or pathway
outcomes. Many papers have begun reporting the dose rate used in their
experiments[41,51,68,75–77], but they do not compare their results with other dose rates.
The dose rates used also vary greatly with minimal consistency. This is likely due to the
restrictions of the radiation source being used, which is usually outside of the researchers
control given the difficulty of obtaining permission to use a source. However, given some
of the differences seen by Tseng et al, it becomes more difficult to draw comparisons
between papers that are exploring the same total dose end point but are using
significantly different dose rates.
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CHAPTER THREE
CHARACTERIZATION AND CALIBRATION OF WAKE FOREST Cs137 GAMMA
RADIATION SOURCE

3.1. Introduction
Variations in the emitted dose, as well as the dose profile of radiation sources,
especially those used for research and medical treatment, is an important factor to keep
under consideration during the design of an experiment. All sources are slightly different.
X-ray sources can have different voltage and current inputs, be generated by an x-ray
tube (age and type of tube can affect the resultant x-rays), or an ion-beam (the
composition of the metal target will change the wavelengths of x-rays emitted). Gamma
sources are affected by the element being used and its half-life, so the older the source is,
the weaker the emitted gamma radiation is. Since a gamma radiation source was utilized
for the following experiments, it was necessary to independently verify the characteristics
of the source.
The Cs137 gamma radiation source at Wake Forest is housed in a custom
built irradiator, capable of exposing samples at a variety of dose rates using different
sized inserts and beam shapers, and can handle many different sample types and sizes
(small cell culture flasks up to small animals). This source is calibrated and maintained
by a group of radiation physicists at Wake Forest. The purpose of this calibration is to
verify the defined dose characteristics for this source and create a repeatable protocol that
can be used to characterize and calibrate any source of ionizing radiation.
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3.2. Materials and Methods
Gafchromic EBT2 dosimetric films were irradiated in parallel to cell culture
samples. Individual films were place underneath the cell culture vessel (in the path of
radiation) in order to provide a dose reading as close as possible to the dose absorbed by
the cells. During travel, the films were kept in an aluminum lined envelope in order to
limit any secondary exposure. Irradiated films were shipping to the Rotating Gamma
Institute in Hungary for analysis.

Figure 3.1: Calibration curves determined from irradiation with the Gamma Knife at the Rotating Gamma Institute
in Hungary. This calibration provides an RGB breakdown of the film color change, allowing precise determination
of dose based upon the amount of darkening seen on the film.

In order to calibrate the film and the colorimetric change it under goes
after exposure to high energy photons, films were irradiated using the Co60 Gamma
Knife at the Rotating Gamma Institute. Irradiation was done by placing film in the center
of a 16cm spherical water equivalent dosimetric phantom and performing exposure for
various lengths of time to achieve a range of doses. Separately, a 0.016cm3 Pint Point 3D
ionization chamber with a certified calibration was positioned identically to the film in a
different 16cm spherical water equivalent dosimetric phantom. This chamber was
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irradiated for the same durations as the film, taking into account changes in air
temperature and pressure, to determine the absolute doses. Finally, the films were
scanned by a high resolution precision scanner and analyzed using the FilmQA Pro
evaluation software. The derived calibration curves can be seen in Figure 1. The
calibration was verified by irradiating another set of films with a calibrated cobalt gun,
seen in Figure 2, ensuring that the known dose given by the gun was the same that the
calibration curve predicted.

Figure 3.2: Dose distribution from a single burst of
a calibrated cobalt gun.

The films irradiated at Wake Forest were scanned, loaded into the FilmQA
Pro software, and fit with the calibration curve in order to verify the dose given. A dose
map was created for the entire irradiated area, enabling an average dose to be calculated.

3.3. Results and Discussion
Point by point RGB analysis of each Wake Forest calibration film was performed.
Total dose exposure was 0.5Gy, 1.0Gy, 2.0Gy, and 4.0Gy as calculated by the source
parameters set by Wake Forest radiation physicists. Figure 3 shows the full histograms
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for each total dose tested. The film for 0.5Gy matched perfectly with the calibration at
0.5Gy, while the higher doses were slightly off with the 4.0Gy dose being off by about
0.2Gy. The dose applied to each film represents an average dose seen in the entire
radiation chamber. Since this source does not create a ‘beam’ of radiation, the spread out
nature guarantees that there will be areas within the chamber that receive higher or lower
doses than the average. This variation is visualized in Figure 4, where higher doses can
be seen to have much more variability over the area of exposure.

Figure 3.3: The distribution of point by point dose analysis for each of the Wake Forest test films.

The slight increases in the measured dose compared to the calculated, given dose
are small and were determined to be insignificant enough to significantly affect any
results gained from this source. The knowledge and experience gained from doing a
calibration in this manner will greatly assist the calibration and characterization of other
ionizing radiation sources that are being explored for biological experimentation.
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Figure 3.4: Heat-maps of the dose distribution for each Wake Forest test film.
Hotspots can be seen around the center of the films, with the magnitude of
difference with the average increasing as the total dose gets larger.

36

CHAPTER FOUR
AIM 1: ADIPOSE STEM CELL PROLIFERATION AFTER GAMMA IRRADIATION

4.1. Introduction
Ionizing radiation exposure today is meant to diagnose and treat disease while
leaving healthy tissue unharmed. This type of radiation exposure accounts for
approximately 50% of the radiation exposure experienced by people in the United
States[1]. The methods of application lie within 3 general categories: external beam
radiation (gamma knife surgery, CT imaging), internal radiation (radioactive seeds
implanted inside the body), and systemic radiation (radioactive solution injected for
palliative care)[2]. Regardless of use, these modalities will apply dose to healthy tissues
within the irradiated volume. While improvements in the technology, physics, and
planning have continued to reduce healthy tissue exposure, complete elimination is not
possible yet[3,4].
Despite the lower dose delivered to a patient during an imaging procedure, the
rising number of procedures performed (CT most notably) has been connected to a rising
collective dose within the population[5–8]. Radiation in cancer treatment utilizes
significantly higher energy and dose (approximately 45-60Gy), that can result in damage
of living tissue[1,2]. These treatments are typically given as a fractionated procedure,
often multiple individual doses of 1-2Gy given over a period of several weeks. This
limits the total dose of a single exposure, thus minimizing damage to surrounding healthy
tissues.
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Radiation therapy at its most fundamental level is meant to eradicate cancer cells
and tissue. This is achieved through the ability of radiation to cause damage to the DNA
and other structures within the cell, and thereby eliminate sustained proliferative
capacity[9,10]. All cells have mechanisms to repair DNA damage, but the extent of
damage and errors can limit the efficacy of these mechanisms[11]. Signaling within the
cell will occur when damage is detected causing cell cycle arrest, providing time for
repair to occur, but if repair is not possible, the cell will proceed through apoptosis.
Stem cells residing in tissues are partly responsible for the regeneration and
healing once the cancer has been eradicated, but it is currently unclear how the radiation
exposure affects the stem cells’ ability to perform these tasks. There is evidence to
suggest cells have built-in protection mechanisms, such as hormesis at very low doses,
which predicts beneficial responses to radiation[12], antioxidant defenses that could
mitigate lipid peroxidation[13], and DNA repair mechanisms through the p53
pathway[14]. Other naturally occurring molecules have been tested for their
radioprotective qualities on cells, such as platelet factor 4 (PF4)[15]. Chen et al. found
that incubating cells with PF4 prior to radiation exposure caused a decrease in cell cycle
regulation gene expression, leading to the conclusion that PF4 could cause a temporary
cell cycle arrest before irradiation, protecting the cell from major damage.
The differential potential of stem cells after irradiation has also been a concern
considering the tissue regeneration stem cells are supposed to spearhead at an injury site.
It has been shown that mouse embryonic stem cells maintain their pluripotency potential
despite having a significant number of chromosomal aberrations[16]. Aberrations form at
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a specified rate in non-irradiated cells, but tend to be of the “simple” variety that can be
fixed by intracellular repair mechanisms. Radiation exposure causes an increase in
“complex” aberrations which can cause problems if not repaired. Bone-marrow derived
stem cells have also been tested to see if radiation exposure alters in progress
differentiation. It was shown, despite an increase in DNA breaks, osteogenic
differentiation was not impaired[17].
Stem cells hold an important niche within the body, not just acting as the source
for new cells of a specific tissue type. They are crucial at an injury site, promoting faster
healing and tissue recovery[18,19], as well as their inherent ability to differentiate into
multiple lineages of cells[20]. These properties make it important to study the effects
ionizing radiation has on stem cells, since a better understanding could lead to better
treatment protocols and faster recovery times for patients receiving radiation. Human
adipose stem cells (hADSC) have not been extensively studied in conjunction with
radiation even though they are prevalent in sites near commonly treated tumors by
radiotherapy (e.g., breast cancer), and have been shown to have significant potential for
tissue repair. This study aims to determine the impact various levels of low to
intermediate gamma radiation has on hADSCs.

4.2. Materials and Methods
4.2.1. Cell Culture and Radiation Exposure
Human adipose-derived stem cells were acquired from ATCC (PCS-500-011,
Manassas, VA); these cells are from lipoaspirates of white adipose tissue from multiple
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healthy donors and have been screened to be positive for mesenchymal stem cell markers.
The cells were cultured in high glucose Dulbecco’s Modified Eagle Medium (Corning;
Corning, NY) supplemented with 10% Fetal Bovine Serum (Atlanta Biologicals; Flowery
Branch, GA) and 1% penicillin-streptomycin (HyClone; Logan, Utah). Cells were
passaged once they reached 80% confluence using 0.25% Trypsin in EDTA (Corning),
plated at about 5,000 cells/cm2 in 6-well plates and incubated at standard culture
conditions (5% CO2, 37°C). Cells were allowed to expand for 2 days prior to irradiation.
Radiation exposure was performed at doses of 0.5Gy, 1.0Gy, and 2.0Gy using a
custom Cs137 gamma irradiator. Exposure was given in a single burst at a dose rate of
3.24 Gy/min. To account for any attenuation from the tissue culture plastic, total dose to
the cells was confirmed independently using gafchromic film placed inside culture plates.
Cells for all conditions (i.e. control and irradiated) were transported to the site of
irradiation in a custom, portable incubator that can maintain proper environmental
temperature conditions.
Measurement of radiation in this experiment was done using Gray’s (Gy).
Sometimes radiation dose is reported in Sievert’s (Sv). While there are specific
distinctions between the two units, for the type of radiation used here (gamma radiation),
1Gy is considered to be equivalent to 1Sv.
4.2.2. Cell Proliferation
After exposure, cell proliferation was monitored for 3 days using CellTiter96®
Aqueous One Solution (Promega; Madison, WI). This solution is an MTS based,
colorimetric assay that measures the formazin product released by cells in culture. The
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formazin product is directly proportional to the number of live cells in culture, therefore
it is possible to calculate the total cells by converting the absorbance value at 490nm. At
each time point, culture media was changed and the CellTiter96® solution was added
directly to the wells according to the manufacturer’s protocol. Cells were allowed to
incubate with the solution for approximately 1.5 hours, then the supernatant was
transferred to a 96 well plate for absorbance reading from a Synergy H1 Biotek plate
reader. Absorbance measurements were converted to cell number using a standard curve
previously obtained.
4.2.3. Cell Imaging
Cell proliferation and cell morphology was assessed by optical microscopy using
a Zeiss Axioskop 2 Plus microscope (Carl Zeiss Microscopy LLC, Thornwood, NY) and
analyzed with ImageJ (National Institutes of Health)[21]. In addition, a Live/Dead
viability assay (L3224, ThermoFisher, Waltham, MA) was performed to determine the
prevalence of dead cells in culture. Cells were stained using the fluorescent dyes calcein
AM (live cells) and ethidium homodimer-1 (dead cells).
4.2.4. Cell Cycle Analysis
Cell cycle analysis was performed using a Guava EasyCyte™ Flow Cytometer
and the Guava Cell Cycle Reagent which stains cellular DNA with propidium iodide
(4500-0220, EMD Milipore, Darmstadt, Germany). Cells were cultured in T25 flasks at
10,000 cells/cm2 and incubated at standard culture conditions. Cell samples in triplicates
were trypsinized everyday out to 48 hours post exposure, then fixed in ice cold 70%
ethanol dropwise and stored at -20°C for at least 12 hours. Before analysis, cells were
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centrifuged and washed in PBS twice, then resuspended in the Guava Cell Cycle Reagent
and incubated at room temperature for 30 minutes in the dark. Up to 5000 total events
were read from each sample, with cells being categorized as being G0/G1, S, or G2/M
phase depending on fluorescence intensity. Results were gated to exclude debris and the
sub G0 population.
4.2.5. Statistical Analysis
All tests were performed with n=3. Statistical analysis was performed using the
JMP stats program. Significance testing was done with either a Student’s T-Test or a
One-way ANOVA (p<0.05).

4.3. Results
After radiation exposure, a significant reduction in viable cells is observed, as
seen in Figure 1. All experimental groups are significantly different (p<0.01) from
control groups at all time points except for the 1Gy group at day 1. All other samples and
time points see a significant decrease in cell number. Using standard microscopy,
verification was performed regarding the total number of cells present in culture. Figure
2 shows the start and end points for this verification, with irradiated samples clearly
having fewer cells than non-irradiated samples. In conjunction with the total cell number,
the rate of growth after radiation exposure closely matches the rate of non-irradiated cells
after the 6 hour time point. While there is some variability in the slopes at higher doses,
the general trend is similar to control samples. Analysis of the microscopy images did not
show any significant change in cell morphology after irradiation (Figure 2). Cells
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retained their spindle-like morphology and there were no significant differences in cell
area or aspect ratio. The Live/Dead assay results showed very few dead (red) cells in any
of the conditions (Figure 3).

Figure 1: Total cell number over a period of 3 days after radiation exposure. All
samples were seeded with 10,000 cells 24 hours prior to exposure (t=0).
Increasing dose corresponds to a reduced cell number (p<0.01), but the growth
rate is generally the same as controls after Day 1.

Figure 4.2: Cells in culture after 2Gy irradiation. (a) and (b) are 0 hours post-exposure, and
(c) and (d) are 96 hours post-exposure. (a) and (c) are controls, while (b) and (d) are the
exposed group.
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Cell cycle analysis is shown out to 48 hours post irradiation (Figure 4). This
experiment observed an increase in the number of cells in the G0/G1 phase, along with a
decrease in both S phase and G2/M phase when compared to control samples. There is no
significant difference between samples in all phases until Day 2. At this time, significant
differences can be seen in the samples irradiated with 1Gy and 2Gy. Compared to control
and 0.5Gy irradiated cells, there are significantly more cells in G0/G1, with fewer cells in
S phase and G2/M (the number of 1Gy irradiated cells in G2/M is not significantly

Figure 4.3: Representative Live/Dead images of (a) non-irradiated control cells and (b)
0.5Gy, (c) 1.0Gy, and (c) 2.0Gy irradiated cells. No dead cells (red) appear in the
samples. Bar = 2000µm.

different from control and 0.5Gy irradiated cells). There are also no significant
population differences in cell cycle phase distribution between all time points for 1Gy
and 2Gy irradiated cells.
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Figure 3.4: Cell cycle analysis out to 48 hours post irradiation. By Day 2, the 1Gy and 2Gy samples had
significantly different fractions of cells in all phases from the 0Gy, control samples (p<0.05).

4.4. Discussion
The experiments reported here have shown a strong correlation between the total
dose of radiation received and the proliferation response of hADSCs. As the total dose of
radiation rises, the initial growth rate of the cells in culture decreases, which is seen
frequently around the literature in many different cell types[16,17,22,23]. However, after
24 hours, the rate of growth closely matches non-irradiated cells. During the first 24
hours after radiation exposure, the cellular repair mechanisms have been activated,
arresting the cell cycle in order to determine the extent of damage. Previous literature has
shown that this arrest can last up to 48 hours, but can vary based on cell type and
experimental model[12,16,17,24].
A significant shift in cell cycle phase populations is seen 2 days after irradiation.
Some literature has reported shifts as early as 24 hours after exposure, but with different
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cell types[25,26]. While the most pronounced differences are with the highest total dose,
a suppressive effect can still be seen in the lowest dose when compared to controls. It has
been shown previously on other cell types that pauses in the cell cycle are
common[17,24,27,28]. What differs is the stage of the cell cycle that the pause occurs in,
lending credence to the fact that different cell types react differently to ionizing radiation.
This experiment saw a pause in the G0/G1 phase for the highest 2 doses that was
consistent for 2 days post-radiation exposure, while the lowest, non-control dose began
returning to control levels by that same point. This suggests that the length of time the
cell cycle pause lasts is proportional to dose.
Cells that cannot be repaired will undergo apoptosis, removing themselves from
the population of healthy, viable cells. Apoptotic cells have exited the cell cycle,
remaining at whatever cell cycle checkpoint they were at until the cell finally dies,
removing itself from the pool of counted cells[27]. Due to the nature of the cell cycle
assay, early apoptotic cells could have been included in the cell cycle data. However, the
Live/Dead assay showed very little dead (red) cells in any of the conditions and at any
time point. Therefore, the doses used in these experiments do not seem to show an
increase in cell death. This suggests that these doses (2Gy or less) of gamma irradiation
were below the critical threshold required to elicit significant cell apoptosis in these
adipose stem cells.
The importance behind these results becomes clear when looking at the full
system that is affected during any kind of radiation exposure (e.g. radiation therapy,
medical imaging). While doses experienced during diagnostic imaging range from 0.01-
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100mGy, doses received from cancer therapy range between 1-2Gy for a single fraction.
Human adipose derived stem cells are a source of naturally occurring reparative cells that
are located around areas typically treated by radiotherapy. Understanding how these cells
respond to the low to moderate doses used in this study could help to better inform
radiotherapy treatment plans[29]. In most cases, the system being exposed is a specific
region of the human body, though occasionally larger sections of the body are exposed at
once such as during imaging[3,30]. Current technology does not have the capacity to
target only tumors, or obtain the equivalent of the high quality images provided by CT
scanners. Until this is the case, healthy cells and tissue will be affected by ionizing
radiation during these instances, which can lead to increased healing time, chromosomal
aberrations that lead to cellular mutation or death, or an increased risk of cancer
formation[23,31,32]. Fully understanding how healthy tissues and cells respond to
relevant doses of ionizing radiation is key to better predicting how the body will respond
to a treatment, and in turn, providing better care for patients.

4.5. References
[1] M. Donya, M. Radford, A. Elguindy, D. Firmin, H. Magdi, Radiation in medicine :
Origins , risks and aspirations, Glob. Cardiol. Sci. Pract. 57 (2014).
[2] J.W. Hodge, C. Guha, J. Neefjes, J. Gulley, Synergizing Radiation Therapy and
Immunotherapy for Curing Incurable Cancers: Opportunities and Challenges,
Oncology. 22 (2008) 1064–1084.
[3] R. Shridhar, K. Almhanna, K.L. Meredith, M.C. Biagioli, M.D. Chuong, A. Cruz, et
al., Radiation therapy and esophageal cancer., Cancer Control. 20 (2013) 97–110.
http://www.ncbi.nlm.nih.gov/pubmed/23749498.

47

[4] Q. Xu, P. Wu, Y. Feng, K. Ye, Y. Tong, Y. Zhou, Gamma knife surgery for brain
metastasis from hepatocellular carcinoma., PLoS One. 9 (2014) e88317.
[5] G. Brix, S. Nissen-Meyer, U. Lechel, J. Nissen-Meyer, J. Griebel, E.A. Nekolla, et
al., Radiation exposures of cancer patients from medical X-rays: how relevant are
they for individual patients and population exposure?, Eur. J. Radiol. 72 (2009) 342–
7.
[6] E.S. Amis, P.F. Butler, K.E. Applegate, S.B. Birnbaum, L.F. Brateman, J.M. Hevezi,
et al., American College of Radiology White Paper on Radiation Dose in Medicine,
J. Am. Coll. Radiol. 4 (2007) 272–284.
[7] K. Guite, J. Hinshaw, F. Ranallo, M. Lindstrom, F.T.L. Jr, Ionizing radiation in
abdominal computed tomography; unindicated multiphase scans are an important
source of medically unnecessery exposure, J Am Coll Radiol. 8 (2011) 756–761.
[8] ICRP, ICRP Publication 103 The 2007 Recommendations of the International
Commission on Radiological Protection, Ann. ICRP. (2007) 1–141.
[9] E.M. Tan, R.G. Freeman, R.B. Stoughton, Action Spectrum of Ultraviolet LightInduced Damage to Nuclear Dna In Vivo**From the Department of Experimental
Pathology and the Division of Dermatology, Scripps Clinic and Research
FoundatiOn, La Jolla, California 92037 and the Department of Pathology, , J. Invest.
Dermatol. 55 (1970) 439–443.
[10] S. Ritter, M. Durante, Heavy-ion induced chromosomal aberrations: a review.,
Mutat. Res. 701 (2010) 38–46.
[11] M. Aoki-nakano, Y. Furusawa, Misrepair of DNA double-strand breaks after
exposure to heavy-ion beams causes a peak in the LET-RBE relationship with
respect to cell killing in DT40 cells, J. Radiat. Res. 54 (2013) 1029–1035.
[12] L.E. Feinendegen, Evidence for beneficial low level radiation effects and radiation
hormesis, Br. J. Radiol. 78 (2005) 3–7.
[13] S. Jelveh, P. Kaspler, N. Bhogal, J. Mahmood, P.E. Lindsay, P. Okunieff, et al.,
Investigations of antioxidant-mediated protection and mitigation of radiationinduced DNA damage and lipid peroxidation in murine skin., Int. J. Radiat. Biol. 89
(2013) 618–27.
[14] G. Pontarin, P. Ferraro, L. Bee, P. Reichard, V. Bianchi, Mammalian ribonucleotide
reductase subunit p53R2 is required for mitochondrial DNA replication and DNA
repair in quiescent cells., Proc. Natl. Acad. Sci. U. S. A. 109 (2012) 13302–7.

48

[15] J.-J. Chen, Y. Gao, Q. Tian, Y.-M. Liang, L. Yang, Platelet factor 4 protects bone
marrow mesenchymal stem cells from acute radiation injury, Br. J. Radiol. 87 (2014)
20140184.
[16] P. Rebuzzini, D. Pignalosa, G. Mazzini, R. Di Liberto, A. Coppola, N. Terranova, et
al., Mouse embryonic stem cells that survive γ-rays exposure maintain pluripotent
differentiation potential and genome stability., J. Cell. Physiol. 227 (2012) 1242–9.
[17] K. Kurpinski, D.-J. Jang, S. Bhattacharya, B. Rydberg, J. Chu, J. So, et al.,
Differential effects of x-rays and high-energy 56Fe ions on human mesenchymal
stem cells., Int. J. Radiat. Oncol. Biol. Phys. 73 (2009) 869–77.
[18] S.S. Collawn, N.S. Banerjee, J. de la Torre, L. Vasconez, L.T. Chow, AdiposeDerived Stromal Cells Accelerate Wound Healing in an Organotypic Raft Culture
Model, Ann. Plast. Surg. 68 (2012) 501–504.
[19] J.M. Gimble, A.J. Katz, B. a Bunnell, Adipose-derived stem cells for regenerative
medicine., Circ. Res. 100 (2007) 1249–60.
[20] R. Izadpanah, C. Trygg, B. Patel, C. Kriedt, J. Dufour, J.M. Gimble, et al., Biologic
properties of mesenchymal stem cells derived from bone marrow and adipose tissue.,
J. Cell. Biochem. 99 (2006) 1285–97.
[21] W.S. Rasband, ImageJ, (n.d.). http://imagej.nih.gov/ij/.
[22] Y. Li, W. Ma, Z. Feng, Z. Wang, N. Zha, B. Deng, et al., Effects of irradiation on
osteoblast-like cells on different titanium surfaces in vitro, J. Biomed. Mater. Res. Part B Appl. Biomater. 101 B (2013) 9–17.
[23] B.P. Tseng, M.L. Lan, K.K. Tran, M.M. Acharya, E. Giedzinski, C.L. Limoli,
Characterizing low dose and dose rate effects in rodent and human neural stem cells
exposed to proton and gamma irradiation., Redox Biol. 1 (2013) 153–62.
[24] O. Momcilovic, S. Choi, S. Varum, C. Bakkenist, G. Schatten, C. Navara, Ionizing
radiation induces ataxia telangiectasia mutated-dependent checkpoint signaling and
G2 but not G1 cell cycle arrest in pluripotent human embryonic stem cells, Stem
Cells. 27 (2009) 1822–1835.
[25] M.L. Lan, M.M. Acharya, K.K. Tran, J. Bahari-Kashani, N.H. Patel, J. Strnadel, et
al., Characterizing the Radioresponse of Pluripotent and Multipotent Human Stem
Cells, PLoS One. 7 (2012) 1–9.

49

[26] K.D. Wilson, N. Sun, M. Huang, W.Y. Zhang, A.S. Lee, Z. Li, et al., Effects of
Ionizing Radiation on Self Renewal and Pluripotency of Human Embryonic Stem
Cells, Cancer Res. 70 (2010) 5539–5548.
[27] C.L. Limoli, E. Giedzinski, R. Rola, S. Otsuka, T.D. Palmer, J.R. Fike, Radiation
Response of Neural Precursor Cells: Linking Cellular Sensitivity to Cell Cycle
Checkpoints, Apoptosis and Oxidative Stress, Radiat. Res. 161 (2004) 17–27.
[28] S. Luft, D. Pignalosa, E. Nasonova, O. Arrizabalaga, a Helm, M. Durante, et al.,
Fate of D3 mouse embryonic stem cells exposed to X-rays or carbon ions., Mutat.
Res. 760 (2014) 56–63.
[29] L.E. Kokai, K. Marra, J.P. Rubin, Adipose stem cells: Biology and clinical
applications for tissue repair and regeneration, Transl. Res. 163 (2014) 399–408.
[30] M.E. Raichle, Positron Emission Tomography, Annu. Rev. Neurosci. 6 (1983) 249–
267.
[31] M. V. Sokolov, R.D. Neumann, Radiation-induced bystander effects in cultured
human stem cells, PLoS One. 5 (2010).
[32] R. Lee, S. Sommer, C. Hartel, E. Nasonova, M. Durante, S. Ritter, Complex
exchanges are responsible for the increased effectiveness of C-ions compared to Xrays at the first post-irradiation mitosis., Mutat. Res. 701 (2010) 52–9.

50

CHAPTER FIVE
AIM 2: THE EFFECT OF VERY LOW DOSE X-RAY RADIATION ON
FIBROBLASTS

5.1. Introduction
The prevalence of radiation in the modern environment is a constant concern with
exposure coming from medical imaging devices, cancer treatment, naturally from the
environment or from a disaster area like Fukushima, and from space. All of these
exposure methods have various dose rates, which allows them to be defined as more or
less useful for specific applications, as well as having higher or lower risk of causing
more damage than help. This is especially true when comparing medical radiation
sources such as linear accelerators used for cancer treatment and x-ray sources used for
computed tomography (CT)[1]. While cancer treatment devices are designed to damage
tissue from the use of high-dose radiation, medical imaging devices are considered to
have a negligible impact on the risk of damage due to the extremely low-dose radiation
employed[2]. The fact remains that low-dose radiation is still considered ionizing
radiation and might be capable of causing unwanted damage that can be minimized with
the understanding of the physical and biological processes involved[3,4].
The dose of radiation given to a patient is completely dependent upon the
procedure being performed. Imaging uses lower energy sources that typically emit
ionizing radiation in the x-ray range[5]. Patients are also exposed to them for
significantly less time and the radiation is spread over a larger interaction volume. This
means that the total effective dose of radiation a patient could receive from an imaging

51

source is between 0.001mSv to 40mSv depending on the location and type of imaging
being performed (e.g, planar x-ray, CT, or nuclear)[3,6].
In contrast, radiation used for cancer therapy uses significantly higher doses;
tumors can receive a total dose of 20-80Gy. Radiotherapy is currently used in over 50%
of cancer cases[7]. While the total dose is very high, this is typically administered in
fractionated doses of 1-2Gy over the course of several weeks[8]. The purpose behind this
method is to cause enough DNA damage to the cancer cells to induce cell death and halt
tumor growth with allowing sufficient time for exposed healthy cells to regenerate
between the treatments. Since it is difficult to avoid exposing healthy tissue to therapeutic
radiation making it necessary to study the impact radiation has on them[9]. The ultrahighdose rate x-ray radiation sources (1010Gy/min) used on cancer cells have been shown to
cause irreparable cell damage due to hypoxia, or cell death by oxygen deprivation. At this
level of ultrahigh-dose x-ray radiation, it has been suggested that oxygen levels decrease
and react with the radiation-induced free radicals[10]. A large spectrum of energy
microdepositions is then produced, leading to the formation of free radical species
through excitations and ionizations. The free radical species generate three major types of
DNA damage: base damage (BD), single-strand breaks (SSB), and double-stranded
breaks (DSB). Chromatin decondensation may hinder the repair of DSB and cause it to
accumulate. The accumulation of unrepaired DSB may also occur in space radiation
exposure, leading to chromosome breaks and the production of rogue cells[11].
Radiation occurs naturally in the environment, given off by elements present in
the earth, as well as a small amount of cosmic rays that reach the earth’s surface. Average
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exposure per year is approximately 2mGy in the United States, but can vary considerably
depending on location and elevation[12]. Radiation exposure in space is much higher
because of the loss of atmospheric protection. Astronauts will typically be exposed to
approximately 400µGy per day during a space mission; however, that dose can be
significantly higher due to events such as solar flares[9].
A commonly accepted radiobiological theory for understanding radiation induced
biological effects is that the dose is directly proportional to the number of radiationinduced DNA damage linked to physical energy deposition[11]. Radiobiological theory
states that mutation frequency is proportional to the dosage absorbed[13]. This describes
the linear-no-threshold model, which is based on the assumptions that any dose, no
matter how low, has a cancer risk [14]. The risk per unit dose is constant and independent
of dose rate and is additive, increasing as dose increases. Recent experimental findings do
not support the linear-no-threshold model for low dose radiation[15]. Results demonstrate
that the cancer risk at low doses is much lower than predictions from the linear-nothreshold model[6]. The accepted belief that all ionizing radiation regardless of dose is
harmful does not seem to be supported by recent research findings.
There are indications that the linear-no-threshold model fails for low dose
radiation and instead supports the theory of a hometic response[16]. The model of
radiation hormesis assumes that low-dose radiation may have beneficial mechanisms that
prevent spontaneous cancers and other adverse health effects through adaptation. These
protective processes are activated by intracellular and intercellular pathways that signal a
natural protection against cancer and other genomic-instability-associated diseases[17].
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This radiation induced hermetic response uses apoptosis, induction of the DNA-repair
pathways, scavenging free radicals, secretion of cytokines and growth factors, and
compensatory cell proliferation to rid of cancer cells. At low dose radiation, the cell uses
adaptive and compensatory strategies for protection[6]. One of the ways that low dose
radiation protective is by activating the immune system leading to faster wound healing
and increases resistance to infection and toxins[12].
There is an increasing need in medicine, biology, and space research for
the understanding of the effects of different types of radiation on healthy human cells.
Studies on the effect of low-dose radiation on cells have shown wide ranges of results
due to the variation in cell types, radiation source, and dose[18]. For instance, some
studies have shown no effect of low-dose (<0.1Gy) radiation on cells, but others have
suggested that low-dose x-ray radiation could have positive effects on the proliferation of
cell types such as fibroblasts and osteoblasts. Low dose x-ray radiation is thought to
accelerate the proliferation of osteoblast cells in vitro and in vivo, and has been shown to
accelerate fracture healing of closed femoral fractures in rats[19,20]. In addition, lowdose radiation can induce a type of adaptive mechanism that allows normal human
fibroblasts to protect themselves from later, higher doses of radiation[21]. While the
mechanism behind this effect is unknown, it has been hypothesized that it may be due
either to an increase in APE protein, which repairs DNA, or induces the failure for cell
cycle checkpoints to occur[22].
Our study aims to determine the effect of low dose (< 250μGy) x-ray
radiation on fibroblast cells in vitro using a characteristic x-ray source with a well-
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defined wavelength. Since even low dose radiation is known to affect the cell cycle, we
hypothesize that the exposure will stimulate fibroblast mitosis leading to increased
proliferation of cells over time.
Fibroblasts were chosen for this study because they are found in many connective
tissues and are critical in the wound healing process due to their ability to secrete woundhealing proteins in the presence of tissue damage. Fibroblasts break down the fibrin clot
at an injury site, as well as aid in the synthesis and repair of extracellular matrix and
collagen[23]. In vitro, the NIH 3T3 fibroblast cell line is well studied and experiences
proliferation at a very high rate, which allows for the effects of irradiation on
proliferation of these cells to be easily observed. In addition to using a well-defined and
characterized cell line, this study will use a novel source producing characteristic x-rays
as opposed to the standard x-ray tube source that produces a mix of Bremsstrahlung and
characteristic emissions[24]. Characteristic x-rays have much narrower wavelength
bands; thus, the type and dose of x-rays given to the cells in this study are much more
controlled than previous similar studies[25].

5.2. Materials and Methods
5.2.1. Cell Culture and Mylar® Cup Assembly
NIH 3T3 mouse fibroblast cells were cultured on 6µm thick Mylar® sheets
pressed between small high-density polyethylene (HDPE) components (Chemplex
Industries Inc., Palm City, FL; Figure 1). Mylar® was used as it is thin enough to allow
for minimal attenuation of the x-ray beam during irradiation. The cells were plated at a
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density of about 1,000cells/cm2 with 2mL of standard culture media containing high
glucose Dulbecco’s Modified Eagle’s Medium (DMEM), 10% Fetal Bovine Serum
(FBS), and 1% penicillin-streptomycin. Cells were incubated in standard culture
conditions (5% CO2, 37°C), and were given approximately 12 hours to adhere to the
Mylar® surface before radiation exposure.

Figure 5.1: Mylar® and individual cup components that make up the
cell culture system. Mylar® (A) provided a surface that allowed cells
to grow in the same manner as if grown on standard tissue culture
plastic, while also being thin enough to allow x-rays to pass through
without attenuation. The Mylar® was pressed between the inner (B)
and outer (C) cup components with a ventilation cap (D) to allow
proper air flow.

Before assembly, the individual components of the cup were cleaned with 100%
ethanol. This was accomplished by placing all components in a 500mL bath for 30
minutes while being agitated with a stir bar at 300rpm. Finally, the components were
rinsed in sterile 1X Phosphate Buffered Saline (PBS) and allowed to dry. The Mylar®
sheets were submerged in a bath of 100% ethanol for 1 minute, then rinsed with 1X PBS
and allowed to dry.
Assembly consisted of a Mylar® sheet (Figure 1A) being stretched over the outer
cup component (Figure 1C). The inner cup component (Figure 1B) was then positioned
over the opening of the outer cup component and was firmly pressed together until a
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snap was heard. The cups were then closed with a cap that allowed for ventilation
(Figure 1D).
5.2.2. X-Ray Radiation Instrument
A new x-ray fluorescence irradiation station was designed and built for these
studies. Broad wavelength x-ray radiation was produced by a pyroelectric Amptek CoolX x-ray generator and used for generating characteristic x-rays off a variable material
fluorescent plate. By changing the plate material the energy of x-rays interacting with the
cell cultures can be controlled and kept near-monochromatic. A solid state x-ray detector
operating in single photon counting mode was used to measure the x-ray flux at the
position of the sample holder. During the irradiations the same detector was used at an off
angle position to monitor the stability of the source.
Standard polystyrene and custom Mylar® cell culture dishes were tested using the
above described x-ray fluorescence setup. An iron plate below the sample holder was
coated in multi-vitamin powder to allow several monochromatic x-ray lines to be emitted
at the same time to study the x-ray energy dependence of transmission. Various cell
culture dishes were tested for x-ray transmittance[24]. Standard tissue culture plastic
attenuates the x-ray beam significantly. Mylar® sheets, on the other hand, provided a
good culture surface while still being thin enough that more than 99% of x-rays passed
through the base of the cup[24].
The cell samples were irradiated using an iron fluorescent plate emitting
Kα and Kβ characteristic lines at 6.4keV and 7.1keV energies respectively. The relative
intensities of the Kα and Kβ lines were 5 to 1. Each sample was irradiated for a time
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period of one hour resulting in total doses between 125µGy – 250µGy depending on the
actual output flux of the instrument. The fibroblast culture was placed above the
fluorescent plate so that the x-rays were sent through the base of the Mylar® cup (Fig. 2)
with very small attenuation.
Measurement of radiation in this experiment was done using Gray’s (Gy).
Sometimes radiation dose is reported in Sievert’s (Sv). While there are specific
distinctions between the two units, for the type of radiation used here (gamma radiation),
1Gy is considered to be equivalent to 1Sv.
The above radiation procedure was implemented and performed to complete the
following assays: cell proliferation, bicinchoninic acid, and cell cycle analysis using flow
cytometry.

Figure 5.2: Experimental setup. The radiation source (A) targeted
the cell culture by fluorescing off the iron plate (B) before irradiating
the culture through the Mylar® from the base of the cup (C).

5.2.3. Cell Proliferation
The cell proliferation assay required four pairs of fibroblast samples: four samples
were irradiated, and the other four samples served as control. The assay was performed at
24 hour intervals beginning the day of irradiation. Cell proliferation was measured using
CellTiter96® Aqueous One Solution (Promega, Madison, WI), a colorimetric assay that
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measures the formazan product released by cells in culture. The testing solution was
placed in a 96 well plate in triplicates and measured for absorbance at 490nm using a
Synergy H1 Biotek plate reader.

5.2.4. Total Protein Analysis
Four fibroblast samples per condition were used for the Pierce™ BCA Protein
Assay Kit (ThermoFisher Scientific, Waltham, MA), where half of the samples were
irradiated and the other half served as controls. Lysate collections for the BCA assay was
performed at 24 hour intervals beginning the day following the radiation exposure. The
cells were trypsinized and placed into 15mL centrifuge tubes. After removing the
supernatants, the cells were resuspended in 150µL room temperature Mammalian Protein
Extraction Reagent (MPER; ThermoFisher Scientific) in order to collect the lysates. The
lysates were mixed with a working reagent consisting of Pierce BCA Protein Assay
Reagent A/Reagent B, which measures the reduction of Cu+2 to Cu+1 in proteins. The
resultant solution was the placed in a 96 well plate in triplicates before being tested for
absorbance at 562nm in a Synergy H1 Biotek plate reader.
5.2.5. Cell Cycle Analysis with Flow Cytometry
Fifteen total samples were needed to perform Flow Cytometry. Six of the samples
were irradiated, and six served as the corresponding controls for 3 days. The remaining
three samples were controls for Day 0. 3T3 fibroblasts were plated in each up at about
5,500cells/cm2. On each respective day, cells were trypsinized, centrifuged, fixed in ice
cold 70% ethanol, and stored at -20°C in order to suspend the cell cycle. Fixed cells were
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pelleted and rinsed with PBS several times, then resuspended in 200µL of Guava Cell
Cycle reagent (EMD Millipore, Darmstadt, Germany). A Guava easyCyte Flow
Cytometer was used to gather data about the cell cycle.

5.2.6. Staining
Two pairs of irradiated/control samples were used for staining. DAPI
(ThermoFisher Scientific) and phalloidin (ThermoFisher Scientific) were the stains used
to showcase the cytoskeleton of each fibroblast cell (green), the nuclei (blue), and
proteins produced by the cells, specifically collagen (red). A primary antibody of mouse
anti-collagen type I (Hybridoma Bank, University of Iowa, Iowa City, IA) was used to
stain for collagen with a secondary of goat anti-mouse Alexa Fluor 647 (ThermoFisher
Scientific).
5.2.7. Statistics

Figure 5.3: Total cell number increased over time in culture for
both the irradiated and control groups. However, while cells in
the irradiated group had initially lower cell numbers one day
after treatment (* = p<0.05), they proliferated much more
quickly in the days following.
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All statistical analyses were calculated using a Student’s T-test, using an α < 0.05.

5.3. Results
5.3.1. Cell Proliferation
After irradiation, the proliferation assay showed increasing cell numbers for a
period out to 3 days (Figure 3). Cultures in both the irradiated and control groups were
95% confluent by day 5. At Day 1, the irradiated samples displayed slower proliferation
and appeared to pause at 11,000 cells, while the controls nearly doubled in concentration.
By Day 3, the samples showed a statistically significant difference (p = 1.45e-5) in
proliferation rate as they surpassed the controls by about 30,000 cells.

Figure 5.4: (A) BCA anaylsis over 4 days after irradiation (p<0.05).
(B) The normalized data shows the change in protein levels increased
more in the irradiated group than in the control, following a similar
trend to that of the proliferation data.
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5.3.2. Changes in Total Protein Content
The BCA analysis after radiation exposure over four days showed increases in
total protein content present in the cultures (Figure 4). Irradiated cells at day one
expressed a lower amount of protein in comparison to its control counterpart. By day 2,
the irradiated cells surpassed the control by about 130µg/mL and continued to surpass the
control by day 3, however no statistically significant difference was observed.
5.3.3. Cell Cycle Analysis
Cell cycle analysis showed that in comparison to their controlled counterparts, the
irradiated cells had a higher percentage in the G0/G1 phase (Figure 5). However, the
irradiated cells had a smaller percentage in the S and G2/M phase in comparison to their
controls, implying that less time was spent in those stages of mitosis.

Figure 5.5: Cells were measured to determine the percent that
stained positive for the cell cycle phase they resided in: G0/G1, S, or
G2/M (* = p<0.05).

5.3.4. Staining
Immunofluorescent images of the cells (Figure 6) confirmed the findings of the
cell proliferation assay; more cells were observed at days 2-4 in the irradiated samples
than control samples. In addition, cells in the irradiated samples showed staining for type
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I collagen that was similar to the control sample. This suggests that the irradiated cells
still maintained their normal cell function after radiation exposure.

Figure 5.6: After irradiation, control samples (left) and irradiated
samples (right) were stained for collagen (red), nuclei (blue), and
actin (green). Imaging was done on Day 1 after irradiation at 10X
magnification (scale bar = 400µm).

5.4. Discussion
The initial difference in cell number (Figure 3) is likely due to the radiation
inhibiting proliferation for a period of time, possibly as a protective measure to minimize
DNA damage[26]. Cell proliferation is also known to slow down in vitro when the cells
become confluent. Therefore, it is also possible that the dose of radiation kills a portion
of the cells, allowing the remaining cells to proliferate at a greater rate due to the increase
in space[27]. These faster proliferation cells can thus produce protein at a higher rate.
However, this unlikely. The ultra-low doses of x-ray used in this experiment are unlikely
to cause significant cell apoptosis[28,29]. In addition, since both control and irradiated
cultures do not reach near confluency until much later time points (Day 5), it seems
unlikely that the increased proliferation rate seen in the irradiated group at days 2 to 4 is
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due to “uncrowding” of the cultures in this experiment. The increase in proliferation and
protein level at days 2 to 4 is consistent with prior in vitro[30] as well as in vivo[6,12]
studies that showed that ultra-low dose radiation could increase cell proliferation.
The results of the cell cycle assays (Figure 5) are consistent with prior studies
which have shown that low dose (0.1Gy) x-rays can temporarily arrest the cell cycle of
human mesenchymal stem cells in G0/G1 phase[5]. It is thought that by retaining the
nucleus around the DNA, the cell refrains from exposing its DNA to the potentially
harmful environment indicated by the x-rays. DNA becomes most vulnerable during the
G2/M phases of mitosis where the nuclear membrane deteriorates.
The low dose x-ray radiation could have some effect on the genes that regulate the
mitotic stages of the cell cycle, causing them express senescence, where the cells sit in
the G0 phase to keep their DNA intact and protected[31]. After the radiation period and
once any DNA damage has been repaired, the cells could begin to proliferate again. The
data recorded on the graph (Figures 3, 5) emphasizes this assumption, given that a
significantly larger percentage of irradiated cells were found to spend their time in the
G0/G1 phases during day one and three compared to the controls.

5.5. Conclusions
The increased proliferation rate and protein concentration for the irradiated cells
suggests that very low dose soft x-ray radiation might cause an initial pause in cell
proliferation followed by a significant increase cell proliferation[32]. However, the exact
mechanism for this phenomenon is currently unknown[33]. These tests further prompt the
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investigation of more specific responses that cause proliferation change by using various
doses of radiation on several cell types.
The dose used in this study is similar to the x-ray dose received by tissues during
standard clinical x-ray imaging[34,35]. In addition, the organ dose limit recommended by
the National Council on Radiation Protection and Measurements for air flight personnel
and low-earth orbit astronauts is 250mSv- 1.5Sv over 30 days, depending on the
organ[36,37]. Note that for x-rays, a dose equivalent in Sv is the absorbed dose in Gy
since the quality factor for x-rays is 1. If personnel were continuously exposed to x-rays,
this dose limit would translate to a dose rate of about 350µSv/hr, which is very similar to
the dose given to the cells in this study[38]. In addition, the low dose-radiation used in
this study is similar to the increased dose of radiation hypothesized to be experienced by
astronauts in low-earth orbit[11]. Recent in vitro experiments support the hypothesis that
the radiation environment of space could also contribute to the long-term physiological
changes astronauts experience after missions[39].
The data gathered here also demonstrates a need for a better understanding of the
effects of ionizing radiation in biomedical applications. In particular, the results of these
types of low-dose well-characterized irradiation studies could help inform computational
models for better cancer treatment planning. The goal of radiotherapy is to kill tumor
cells. However, it is important to understand how the cells in the vicinity of a tumor will
react to any radiation they may also be exposed to and to test for the extent in which low
dose radiation is harmful to the non-cancerous cells. By running tests and assays to
determine cell death as well as identifying the expression of genes commonly found in
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DNA repair, a better understanding of the mechanism behind the increased proliferation
and protein synthesis could be determined.
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CHAPTER SIX
AIM 3: CHANGES IN IONIZING RADIATION DOSE RATE AFFECT CELL CYCLE
PROGRESSION IN ADIPOSE STEM CELLS

6.1. Introduction
Exposure to ionizing radiation is something cannot be escaped as there is a natural
amount of background radiation found in the environment from extraterrestrial sources
like the Sun, and terrestrial radioactive elements (e.g. Radon). Adverse effects from
ionizing radiation can be limited by minimizing the amount of additional radiation
exposure. The rate at which radiation is emitted (dose rate) has been shown, at least at
high dose rates, to increase the risk of cancer and non-cancer disease formation[1,2].
These observations are based off of the Lifespan Study (LSS) of atomic bomb survivors
who were exposed to various total doses of radiation (depending on the distance from the
bomb) at a very high dose rate. Normal background radiation is 2-4mSv/yr depending
upon location, which is a dose rate that will result in a minimum number of damage
causing ‘hits’ in a cell[3,4]. Diagnostic medical imaging machines, such as computed
tomography (CT), use much high doses of radiation. Depending on the location of the
scan, a patient can receive between 2-20mSv over a period of several minutes[5,6], which
is many times faster than observed from background radiation.
Radiation exposure is commonly used as a treatment for various forms of cancer,
meaning the dose given to a patient must be high enough to cause lethal damage to cancer
cells. Over the course of treatment (weeks), a patient can receive between 40-60Gy given
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in daily, fractionated doses of 1-2Gy[7]. Giving radiation therapy in small fractions is
meant to provide healthy cells and tissue time to repair damage they may have received;
however, the dose rate given during these therapies is many times higher than from
medical diagnostic imaging, causing concern that damage to healthy cells and tissue
could increase the risk for later tumor or non-cancerous disease formation[2,6,8]. Given
the variation in dose rate for these types of sources, it is difficult to determine if there are
any detrimental effects to using a higher or lower dose rate in the Gy/min range.
Also of concern is the frequency with which a patient receives their radiation
treatment. Using fractionated, daily treatments is supposed to provide time for damage
repair. However, numerous in vitro studies have been performed that show most cell
types exhibit hallmarks of damage detection and repair (activation of the p53 pathway,
cell cycle arrest, apoptosis, immune system activation, etc.) up to 2 days following
radiation exposure[9–12]. This points to the possibility that daily fractionated doses is
still too high of a frequency to ensure sufficient recovery of healthy cells. Indeed,
Rødningen et al found correlation between activated genes and the number of doses a
sample received[13]. It is unclear, however, if increasing the time between fractions
could improve the health and survival of non-cancerous.
Comparison experiments on the effects of various dose rates are surprisingly
sparse, with most comparing dose rates that are orders of magnitude different (e.g.
mGy/min vs Gy/min)[14,15]. While it is important to understand the differences in
response cells have to very low dose rate and high dose rate radiation, the reality is that
dose rates that are that different have to come from different sources, and therefore have
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different uses. This experiment aims to understand the differences in adipose derived
stem cell (ADSC) response to 2 different dose rates from the same source. The results
given should continue to shed light on how ADSCs react to ionizing radiation exposure,
and if different dose rates in the same Gy/min range can elicit a different response. It is
the hope that these results could help better inform radiation therapy protocols in order to
ensure healthy cells around a tumor remain as healthy as possible.

6.2. Materials and Methods
6.2.1. Cell Culture and Gamma Irradiation
Human adipose-derived stem cells (hADSCs) were acquired from ATCC
(Manassas, VA) and cultured in high glucose Dulbecco’s Modified Eagle Medium
(Corning; Corning, NY) with 10% Fetal Bovine Serum (Atlanta Biologicals; Flowery
Branch, GA) and 1% penicillin-streptomycin (HyClone; Logan, Utah). One day prior
radiation exposure, cells were passaged and counted using a Scepter™ (EMD Millipore;
Darmstadt, Germany) automated cell counter to ensure the proper cell density was plated
for each experiment. Depending on the experiments being performed during that trip,
cells were either plated in T25, 6- or 24-well plates.
For travel to the radiation facility, cell culture systems were kept in a portable
incubator capable of maintaining proper temperature. Upon arrival, all cell culture
systems were placed in a standard incubator (37°C, 5% CO2) for 1 hour to re-acclimate
the cells and media. After this period, cells were irradiated with a custom Cs137 gamma
irradiated for a total dose of 2Gy and either a low dose rate (LDR; 1.40Gy/min) or a high
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dose rate (HDR; 7.31Gy/min), then placed back in the portable incubator for travel back
to Clemson.
Measurement of radiation in this experiment was done using Gray’s (Gy).
Sometimes radiation dose is reported in Sievert’s (Sv). While there are specific
distinctions between the two units, for the type of radiation used here (gamma radiation),
1Gy is considered to be equivalent to 1Sv.
6.2.2. Proliferation Assay
Proliferation changes were measured in hADSCs after radiation exposure using
CellTiter96® Aqueous One Solution (Promega; Madison, WI). This solution is an MTS
based, colorimetric assay that measures the formazin product released by cells in culture.
The formazin product is directly proportional to the number of live cells in culture,
therefore it is possible to calculate the total cells by converting the absorbance value.
ADSCs were plated at 2,500cells/cm2 in 24-well plates 1 day before radiation exposure to
allow the cells time to adhere. After radiation exposure, the plates were returned to the
incubator, and the assay was performed at 6 hours, 1 day, 3 days, and 5 days post
exposure. The old media was first removed from the wells, then 0.5mL of fresh media
and 100µL of CellTiter96® was added. The plates were then incubated at 37°C and 5%
CO2 for 1 hour, then had absorbance read at 490nm using a Synergy H1 Biotek plate
reader.
6.2.3. Flow Cytometry
Cell cycle and apoptosis distribution were determined using a Guava easyCyte
Flow Cytometer (EMD Millipore). Cellular DNA was stained using a Guava Cell Cycle
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Reagent (EMD Millipore) containing propidium iodide (PI) in order to visualize what
phase of the cell cycle each cell is in. The fluorescent intensity of PI-stained DNA
increases with each progressive phase, allowing a clear indication of the percentage of
cells present in each phase. hADSCs were plated at 5000cells/cm2 in 6-well plates 1 day
before radiation exposure. After exposure, cells were removed from the culture surface
and collected at day 1, 2, and 3 using 0.25% Trypsin in EDTA (Corning). Cells were
pelleted by centrifugation. After removing the supernatant, cells were resuspended and
washed in sterile 1X Phosphate Buffered Saline (PBS; MP Biomedicals; Solon, OH) and
counted. Cell suspension was then plated in a 96-well U-bottom plate at a density of
5.0x104 cells per well. The plate was centrifuged and the supernatant carefully removed
so as not to disturb the pellet. The pellet was broken up by trituration in residual PBS,
then 200µl of 70% ice-cold ethanol was added dropwise to each well while gently
swirling the plate to fix the cells. Fixed cells were washed with 1X PBS to remove
ethanol residue, centrifuged and resuspended in 200µl of Guava Cell Cycle Reagent.
After 30 minutes of incubation at room temperature, the plate was read using the flow
cytometer.
The presence of apoptotic cells was determined using the Guava Mitochondrial
Depolarization Assay kit (EMD Millipore), which uses a fluorescent cationic dye, JC-1.
This dye collects in the mitochondria of healthy cells. When a cell becomes apoptotic, the
membrane of the mitochondria will become depolarized, allowing JC-1 to leak into the
cytoplasm where it’s broken down, changing the color it fluoresces. The kit also includes
a solution of 7-AAD which enters cells and fluoresces when they die. 7-AAD cannot
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enter live cells because their membrane has not been compromised. hADSCs were plated
at 2,500cells/cm2 1 day before radiation exposure in 6-well plates. After exposure, cells
were removed from culture surface using 0.25% Trypsin in EDTA, centrifuged and
resuspended in 200µl media. This cell suspension was transferred to a 96-well flat bottom
plate where it was mixed with 4µl of a JC-1/7-AAD solution. The plate was then
incubated for 30 minutes at 37°C and read using the flow cytometer.
6.2.4. Reverse Transcription Polymerase Chain Reaction (RT-PCR)
hADSCs were seeded at 5,000cells/cm2 in 6-well plates 1 day prior to radiation
exposure. Total RNA was collected from irradiated cells at 4 hours, 1, 2, and 3 days post
exposure using TRIzol Reagent (Invitrogen; Waltham, MA). RNA purification was
carried out per the manufacturer’s instructions. Single-stranded cDNA was obtained
using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems;
Waltham, MA) following the manufacturer’s protocol. cDNA was then amplified in PCR
using PowerUp SYBR Green Master Mix (Applied Biosystems) and specific primers
(CD44 and TP53 from Integrated DNA Technologies, Coralville, IA). Amplification was
performed using a StepOnePlus Real-Time PCR System (Applied Biosystems) with
appropriate settings based upon the SYBR Green protocol.
6.2.5. Immunocytochemistry
Cells for immunocytochemistry were cultured and irradiated in T25 culture flasks
at 1,500cells/cm2. Following radiation exposure, cells were trypsinized and reseeded onto
poly lysine coated Flourodishes (World Precision Instruments; Sarasota, FL) at
2,500cells/cm2. Fixation and staining was done 1, 2, and 3 days post irradiation. Fixation
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was done with 4% paraformaldehyde for 30 minutes at 37°C. Cells were permeablized
using 0.3% Triton-X (Sigma-Aldrich; St. Louis, MO) for 15 minutes at room
temperature, followed by blocking with 5% BSA for 1 hour. After rinsing with PBS, cells
were incubated with 2µg/ml of either monoclonal mouse anti-p21/WAF1/Cip1 (Clone
CP74; EMD Millipore) or monoclonal mouse anti-p53 (Clone PAB1801; Invitrogen)
overnight at 4°C. Secondary blocking was done with 5% donkey serum for 30 minutes at
room temperature. Primary antibodies were then tagged using 4µg/ml donkey anti-mouse
Alexa Fluor 647 secondary antibody (Invitrogen) for 1 hour at room temperature in the
dark. All samples were then counter stained using Alexa Fluor 488 phalloidin and DAPI
according to manufacturer’s protocols. Imaging was performed using an Olympus IX81
spinning disk confocal microscope (Olympus; Tokyo, Japan), while collection and postprocessing was done using MetaMorph Image Analysis software (Molecular Devices;
Sunneyvale, CA).
Antibody expression intensity was analyzed using a custom MatLab program that
separated the image based upon the location of the nucleus, and then compared the
intensity inside the nucleus with the cytoplasmic intensity.
hADSCs were also fixed and stained for β-galactosidase (β-gal) to check for
cellular senescence. Cells seeded in 6-well plates at 2,000cells/cm2 were fixed 4 hours, 1,
and 2 days after radiation exposure, then stained using a Senescence Detection Kit
(BioVision; Milpitas, CA) following the manufacturer’s protocol. After staining, cells
were imaged using an EVOS Cell Imaging System (Advanced Microscopy Group;
Bothell, WA).
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6.2.6. Statistical Analysis
All experimental conditions were performed with a minimum of 3 replicates. Data
was collected and analyzed for statistical significance by a One-Way ANOVA (p<0.05)
using JMP Pro 12 (SAS; Cary, NC).

Figure 2: Total cell number present in culture after 2Gy gamma irradiation.

Figure 6.2: Cell growth rate after 2Gy gamma irradiation. Irradiated samples are
normalized to control at each time point.

6.3. Results
6.3.1. Changes in Proliferation
Exposure to 2Gy ionizing radiation at different rates had minimal effect on the
proliferation of ADSCs. There is no statistical difference in the number of cells in culture
expect for LDR at day 5 where it is significantly different from control, but not HDR
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irradiated samples (Figure 1). Similarly, the proliferation rate between samples shows no
differences (Figure 2). The rate of proliferation was determined by taking the difference
of total cell number between the current and previous time points and dividing by the
time elapsed.

Figure 6.3: (a) Cell cycle distribution after 2Gy gamma irradiation. Separated phase analysis, (b) G0/G1
phase, (c) S phase, (d) G2/M phase, is seen with p<0.05.

6.3.2. Cell Cycle Distribution
Cell cycle analysis by flow cytometry is able to determine the percentage of cells
present in a given phase of the cell cycle: G0/G1, S, or G2/M. Using the Guava Cell Cycle
Reagent, fixed 2Gy irradiated cells were stained and analyzed for differences in cell cycle
distribution between LDR and HDR. Figure 3a shows the full distribution for all samples
over the collected time points. At all time points, HDR samples in G0/G1 were
significantly different than both control and LDR samples, while LDR was significantly
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different than control at day 3 only (Figure 3b). LDR and HDR samples in S phase were
significantly different from controls at day 1, and LDR was different from both control
and HDR at day 2 (Figure 3c). There was no difference between samples in S phase at
day 3. LDR and HDR samples in G2/M phase were significantly different from control at
all time points, and LDR and HDR were different from each other at day 3 (Figure 3d).
6.3.3. Apoptosis Induction
Depolarization of the mitochondrial membrane was used as the determining factor
for the stage of apoptosis a cell may be in (healthy, early-, mid-, or late-apoptotic). A
more depolarized membrane potential corresponds to a later stage of apoptosis. As seen
in Figure 4, the proportion of healthy cells grew over time, but HDR samples 12 hours
after exposure were significantly different from control and LDR samples. Both LDR and
HDR samples were significantly different from control on day 2 for early apoptotic cells,

Figure 6.4: Cell distribution within the various stages of apoptosis as measure by mitochondrial membrane
depolarization (p<0.05).
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though the proportion of early apoptotic cells was relatively consistent over the length of
the experiment. The proportion of cells in the mid-apoptotic stage steadily dropped, but
there were no differences between sample types. HDR sample showed significant
differences from both LDR and control samples 12 hours and 2 days after irradiation.
This experiment displayed a high number of apoptotic cells in all sample types for the
entire duration, with healthy, early apoptotic, and mid-apoptotic each having
approximately ⅓ of the cells.
6.3.4. Specific Gene Expression by PCR
Following irradiation, gene markers for CD44 and TP53 were checked for
changes in expression using PCR. CD44 is a surface protein marker that is commonly
used to characterize stem cells. Significant changes in CD44 expression could indicate
the cell is losing its stemness. Figure 5a shows no significant differences between
samples until day 2 when HDR has higher expression than control and LDR. On day 3,
LDR and HDR are significantly different from each other, but are not different from
control. TP53, also known as p53, is an important protein that is activated in response to
DNA damage from various sources. In this experiment, p53 expression in irradiated
samples is relatively suppressed compared to control. However, the differences are only
statistically significant at day 3 where LDR and HDR are also statistically different from
each other (Figure 5b).
6.3.5. Immunofluorescence
P53 and p21 are both present in the cytoplasm of all samples. Neither of these
proteins are considered activated unless they are in the nucleus, otherwise they are in an

80

inactivated, phosphorylated state. At all time points, nuclei were found to be clear of p53
in all samples except for a few cells in day 1 controls (Figure 6). P21 shown declining

a
*

**
********

b
* **

Figure 6.5: Relative gene expression for (a) CD44 and (b) TP53 in
2Gy irradiated ADSCs (p<0.05).

activation from day 1 to day 3 in all samples. Nuclear expression is clear at day 1 and 2,
but by day 3 it is difficult to distinguish between the background, cytoplasmic expression
and the nuclear expression (Figure 7). The intensity of nuclear staining (Figure 8) showed
no differences between samples.
6.3.6. Senescence
Increased levels of β-gal activity, specifically senescence-associated β-gal (SA-βgal), is a marker of senescent cells. Figure 9 shows representative images of β-gal
staining in hADSCs after radiation exposure. Dark spots are high concentrations of β-gal.

81

Control and LDR samples display high numbers of senescent cells, though it cannot be
determined if there is a difference between them. HDR samples show almost no
senescent cells; however, there are also fewer cells visible in culture compared to control
and LDR.

LDR

Control

HDR

Day 1

Day 2

Day 3

Figure 6.6: p53 expression (red) in irradiated hADSCs, counterstained with phalloidin (green) and DAPI (blue).
Images taken at 40x magnification. Bar = 50µm.
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Control
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Day 1

Day 2

Day 3

Figure 6.7: p21 expression (red) in gamma irradiated hADSCs, counterstained with DAPI (blue).
Images taken at 100x magnification. Bar=20µm.

Figure 6.8: Normalized nuclear intensity of p21 expression. Data is normalized to
control of each time point.
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Control
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4 Hours
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Figure 6.9: Expression of β-gal representing senescent cells. Images taken at 4x magnification.
Bar=1,000µm.

6.4. Discussion
The purpose behind this experiment was to determine how various dose rates
from a Cs137 gamma radiation source affected the growth and damage response
mechanisms in human adipose derived stem cells. There is currently a gap in literature
surrounding these cells and how they react to radiation exposure. Considering their
potential uses in stem cell therapies, the ease with which they can be acquired, and the
tissue they are derived from is present all around the body, hADSCs need to be studied
more in-depth[16–20]. When dealing with cancers that typically have high amounts of
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adipose tissue in the area, such as breast cancer, hADSCs will be the cell type that is
primarily responsible for the recruitment of immune cells, the expression of cytokines
and other molecules to help promote repair, and potential differentiation to replenish a
population of depleted cells.
Following gamma radiation exposure, HDR samples experience a decrease in the
number of healthy cells and the number of cells present in G0/G1 and S phase. There is
also an increase in the number of cells in G2/M phase, which is similar to the response
seen in embryonic stem cells[21,22], although the magnitude is not quite as great. LDR
samples experienced a similar increase in the G2/M phase population, though not by the
same magnitude as HDR. This response is opposite that of bone-marrow derived stem
cells (BMSCs), which is another adult mesenchymal stem cell line frequently used for
stem cell therapy. Chen et al found that hBMSCs had an increase in the number of G0/G1
cells, indicating G1 arrest[9]. Despite hADSCs also being an adult mesenchymal stem cell
line, their behavior in regards to cell cycle arrest mirrors that of embryonic stem cells
much closer than other adult stem cell lines.
Cell cycle arrest after ionizing radiation is induced via the p53 pathway which is
activated by the ATM kinase. Upregulation of p53 will activate p21, a cell cycle
inhibitory protein, or will induce apoptosis if DNA damage is severe enough[23]. In this
study, no significant upregulation of p53 was observed, either through PCR or
immunocytochemistry analysis. By the later time points of the study, a significant
downregulation of p53 was observed in both LDR and HDR, which has not been reported
in other literature. Most studies have reported significant upregulation of p53 in the first
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couple hours after radiation exposure, followed by a decrease in expression back to
control levels by 24 hours[21,24]. Due to the model used in the study, capturing data
points earlier than 4 hours after exposure was impossible. The low levels of p53
expressed in hADSCs could indicate very rapid activation then inactivation of p53
resulting in rapid activation of downstream targets relative to other cell types. Indeed,
p21 activation is seen 24 hours after radiation exposure, maintaining increased expression
through day 2 in both sets of irradiated samples, though no difference is seen. This
expression is consistent with the continued G2 checkpoint arrest seen at day 3. The short
term cell cycle arrest seen here is characteristic of p21; however long term exposure or
high levels of p21 can also cause cellular senescence[25]. Radiation induced senescence
is typically a hallmark of tumor cells, although there is no reason why healthy cells
couldn’t also enter a senescent state if exposed to the right set of conditions. LDR
samples in the study showed a significant number of senescent cells compared to HDR
samples, suggesting that the lower dose rate could help lead to senescence induction
instead of apoptosis. However, control samples also showed a high number of senescent
cells, so it is likely that the response in LDR samples is nothing more than a normal
response for hADSCs.
hADSCs in culture are never 100% arrested, like what is seen in embryonic stem
cell culture after radiation exposure. Proliferation still occurs in the cells that have not
been arrested due to p53/p21 activation, although a slight decrease in proliferation rate
can been seen at day 3. This could be due to the significantly increased number of cells
present at the G2 checkpoint combined with a decreased number of apoptotic cells. The
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rate of proliferation is also not different from control, so the drop could just be part of the
natural growth of hADSCs.
The number of differences between LDR and HDR samples in this study is
minimal, although the differences seen in p53 expression and cell cycle arrest are
certainly significant as these are key regulators for the recovery of the cell after radiation
exposure. While the differences in the dose rates used was not as great as other studies,
the rates used here are both relevant for cancer therapy. The differences between
radiation sources used for cancer treatment can vary enough that there could be an effect
on the healthy cells in the tissue surrounds the tumor. The results shown here would
suggest that differences in dose rate in the Gy/min range has a minimal effect on the
function of hADSCs.
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CHAPTER SEVEN
CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE WORK

7.1. Conclusions
The presented research is motivated by a desire to increase our understanding of
the cellular changes adipose derived stem cells (ADSCs) experience after being exposed
to radiation therapy relevant doses of gamma radiation. These cells have shown great
promise for research areas like tissue engineering and regenerative medicine[1–3]. For
certain cancers, like breast cancer, adipose tissue is one of the main tissue types present,
making it highly likely that ADSCs contribute heavily to tissue repair once the tumor is
removed. Being able to better predict how these cells react to radiation exposure could
help inform better treatment procedures for patients, leading to quicker recovery.
In Chapter 4 we discussed the reaction of ADSCs to different total doses of
gamma radiation. While the results appeared to show suppressed growth with increasing
doses of radiation, a closer look revealed that most of the effect seen was due to what
happens in the first 24 hours after exposure. The rate of growth for the remainder of the
experiment was consistent between all samples. A similar result is seen in Chapter 6 after
exposure to different dose rates. Despite some differences in the count of total cells, the
rate of growth between samples was not different.
Cell cycle analysis supports the minimal differences seen in proliferation. Results
from both Chapter 4 and Chapter 6 show significant differences between control and 2Gy
irradiated samples and with both dose rates. Compared to previous literature on
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embryonic and bone-marrow derived stem cells (ES and BMSC, respectively), the
changes are not that drastic. ES cells have a naturally short G1 phase in order to avoid
unintended differentiation, so many more cells are present in S phase. However, after
radiation exposure, the fraction of S phase cells drops from 50-60% down to about 20%,
while G2 phase cells increase from about 20% to 75%[4,5]. BMSCs experience a
different change, with an increase in G0/G1 phase cells from 80% to 90% and a drop in S
phase cells almost to 0%[6]. ADSCs, on the other hand, never experience a complete
depletion of one phase of the cell cycle. Despite the significant differences seen between
samples, there is never a huge swing of the cell population from one phase to another.
The minimal expression of nuclear p53 and p21 suggests that significant cell cycle arrest
is uncommon, or occurs very soon after radiation exposure and resolves shortly
thereafter. Expression of p53 and p21 in ES and BMSCs cells has been shown to occur
approximately 2-4 hours after radiation exposure, levels still elevated after 24 hours[4,6].
The results for ADSCs show that after 6 hours, there is no difference in expression with
controls providing further evidence that p53 is upregulated, then downregulated back to
control levels within 6 hours after radiation exposure.
It is known that all cell types react to stimuli differently. This is especially true
with such a strong stimulus like ionizing radiation, making it all the more important to
study many different cell types. ADSCs are certainly impacted by exposure to ionizing
radiation, but not to the same extent that similar cells (ES and BMSCs) are affected. The
leads to the conclusion that ADSCs are more radioresistant than other stem cells, making
them an even more ideal option for regenerative medicine and tissue engineering. ADSCs
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also showed some significant differences between LDR and HDR radiation, especially in
cell cycle and gene expression analysis. These differences occur at later time points,
however. LDR and HDR are similarly difference from control at early time points,
suggesting that HDR radiation takes longer to recover from.

7.2. Recommendations for Future Work
7.2.1. Verification Using a Different Radiation Source
The use of the gamma radiation source at Wake Forest was thanks to a connection
with Dr. Jeff Willey who frequently using the same source for his own experiments.
While we are grateful to Dr. Willey for allowing us access to the source so frequently, the
time it takes to travel to and from Wake Forest causes concern that the cells are being
exposed to a secondary stressor that may influence the results. Using another radiation
source that significantly reduced or eliminated the need to travel would be ideal for future
experiments.
7.2.2. Continue the Exploration of Ultra-Low Dose Radiation
The results seen in Chapter 5 show positively that even radiation in the µGy range
has an effect on cells. It’s been hypothesized that ultra-low dose radiation may have
beneficial side-effects that have yet to be fully explored. Dr. Endre Takacs’s lab in
Clemson’s Department of Physics and Astronomy has recently completed a fully
contained, customized x-ray box capable of delivering total dose in the mGy range
(relevant to medical imaging). This box is designed to fit inside a standard incubator,
allowing cell exposure experiments to be as short or as long as desired without needing to
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worry about pH changes in the cell culture media. This system as a whole opens up many
different kinds of experiments to explore, from long term chronic exposure (disaster
areas) to short burst exposure (medical imaging). The source is capable of outputting
different dose rates, allowing tight control over how radiation is delivered to the samples.
7.2.3. Use a More Standard Assay for Apoptosis Detection
The research presented here made use of an apoptosis assay that used
mitochondrial depolarization as a means to determine what stage of apoptosis a cell was
in (early, mid, or late). In theory, this is a unique method of determining apoptosis and
should predict induction of apoptosis pretty well since the release of cytochrome c from
the mitochondria is an early step in the intrinsic apoptosis pathway. However, in practice,
the assay proved to be difficult to use, requiring the user to define where the gates would
be set for each population of cells. Using a more standard method of measurement, such
as Annexin V, would likely produce more consistent, reliable results.
7.2.4. Explore the Effects of the Frequency of Fractionated Dosing
Currently, most radiation therapy procedures use fractionated dosing in order to
limit the amount of radiation exposure to a patient at one time. Typically these are given
daily, 5 days a week. Given that most cell types are still experiencing some sort of effect
from radiation 2-3 days after exposure (i.e. still recovering), receiving 5 straight days of
radiation exposure weekly has to have a compounding effect on the health of those cells.
Being able to explore the frequency with which fractionated doses are given could lead to
a reduction in side effects experienced by patients and potentially decrease the time
needed for recovery.
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Appendix A
Statistical Analysis Output

A.1. Aim 1: Proliferation Stats
Oneway Analysis of Cell Number By Dose Day=0

Excluded Rows

1

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
1.97273

Alpha
0.05

Connecting Letters Report
Level
0
0.5
2
1

Mean
80927.659
60246.936
59903.872
51016.532

A
B
B
C

Levels not connected by same letter are significantly different.
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Ordered Differences Report
Level
0
0
0
0.5
2
0.5

- Level Difference Std Err Dif Lower CL Upper CL
1
29911.13
2141.221
25687.1 34135.18
2
21023.79
2141.221
16799.7 25247.84
0.5
20680.72
2141.221
16456.7 24904.78
1
9230.40
2129.922
5028.6 13432.17
1
8887.34
2129.922
4685.6 13089.10
2
343.06
2129.922
-3858.7
4544.83

p-Value
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
0.8722

Oneway Analysis of Cell Number By Dose Day=1

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
1.97266

Alpha
0.05

Connecting Letters Report
Level
0
1
0.5
2

Mean
157909.18
152369.57
119710.86
101329.48

A
A
B
C

Levels not connected by same letter are significantly different.
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Ordered Differences Report
Level
0
1
0
1
0.5
0

- Level Difference Std Err Dif Lower CL Upper CL
2
56579.71
5820.520
45097.8 68061.63
2
51040.09
5820.520
39558.2 62522.01
0.5
38198.32
5820.520
26716.4 49680.24
0.5
32658.70
5820.520
21176.8 44140.62
2
18381.39
5820.520
6899.5 29863.31
1
5539.62
5820.520
-5942.3 17021.54

p-Value
<.0001*
<.0001*
<.0001*
<.0001*
0.0019*
0.3425

Oneway Analysis of Cell Number By Dose Day=2

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
1.97266

Alpha
0.05

Connecting Letters Report
Level
0
2
0.5
1

Mean
204104.06
153201.14
151011.44
138639.84

A
B
B
C

Levels not connected by same letter are significantly different.
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Ordered Differences Report
Level
0
0
0
2
0.5
2

- Level Difference Std Err Dif Lower CL Upper CL
1
65464.22
4325.522
56931.4 73997.02
0.5
53092.62
4325.522
44559.8 61625.42
2
50902.92
4325.522
42370.1 59435.72
1
14561.30
4325.522
6028.5 23094.10
1
12371.60
4325.522
3838.8 20904.40
0.5
2189.70
4325.522
-6343.1 10722.50

p-Value
<.0001*
<.0001*
<.0001*
0.0009*
0.0047*
0.6133

Oneway Analysis of Cell Number By Dose Day=3

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
1.97266

Alpha
0.05

Connecting Letters Report
Level
0
0.5
1
2

Mean
233804.87
185519.10
179911.19
143161.18

A
B
B
C

Levels not connected by same letter are significantly different.

99

Ordered Differences Report
Level
0
0
0
0.5
1
0.5

- Level Difference Std Err Dif Lower CL Upper CL
2
90643.69
7052.839
76730.8 104556.6
1
53893.68
7052.839
39980.8
67806.6
0.5
48285.77
7052.839
34372.9
62198.6
2
42357.92
7052.839
28445.0
56270.8
2
36750.01
7052.839
22837.1
50662.9
1
5607.91
7052.839
-8305.0
19520.8

p-Value
<.0001*
<.0001*
<.0001*
<.0001*
<.0001*
0.4275

A.2. Aim 3: Proliferation Stats
Oneway Analysis of Cell Number By Sample Type Time Point=6 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.30600

Alpha
0.05

Connecting Letters Report
Level
Negative Control
LDR
Positive Control
HDR

Mean
18203.933
15202.367
13112.000
12844.000

A
B
B
B
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Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

- Level

Negative
Control
Negative
Control
Negative
Control
LDR

HDR

LDR

Positive
Control
HDR

Positive
Control

Difference

Std Err Lower
Upper
pDif
CL
CL Value
5359.933 1296.382 2370.47 8349.397 0.0033*

Positive
Control
LDR

5091.933 1296.382 2102.47 8081.397 0.0044*

HDR

2358.367 1296.382

3001.567 1296.382

12.10 5991.030 0.0493*

- 5347.830 0.1064
631.10
2090.367 1296.382
- 5079.830 0.1455
899.10
268.000 1296.382
- 3257.463 0.8414
2721.46

Oneway Analysis of Cell Number By Sample Type Time Point=24 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.30600

Alpha
0.05

Connecting Letters Report
Level
Negative Control
LDR
HDR
Positive Control

Mean
13487.193
7859.310
7752.113
7752.113

A
B
B
B
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Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

- Level

Negative
Control
Negative
Control
Negative
Control
LDR

HDR

LDR

Positive
Control
HDR

Positive
Control

Positive
Control
LDR
HDR

Difference

Std Err
Dif
5735.080 2364.742

Lower
Upper
pCL
CL Value
281.98 11188.18 0.0415*

5735.080 2364.742

281.98 11188.18 0.0415*

5627.883 2364.742

174.78 11080.99 0.0446*

107.197 2364.742

- 5560.30 0.9650
5345.91
107.197 2364.742
- 5560.30 0.9650
5345.91
0.000 2364.742
- 5453.10 1.0000
5453.10

Oneway Analysis of Cell Number By Sample Type Time Point=72 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.30600

Alpha
0.05

Connecting Letters Report
Level
Negative Control
HDR
Positive Control

Mean
47415.400
33211.667
32407.633

A
A B
A B
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Level
LDR

Mean
28816.533

B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

- Level

Negative
Control
Negative
Control
Negative
Control
HDR

LDR

LDR

4395.13 7681.035

Positive
Control
HDR

LDR

3591.10 7681.035

Positive
Control
HDR

Positive
Control

Difference

Std Err
Dif
18598.87 7681.035
15007.77 7681.035
14203.73 7681.035

804.03 7681.035

Lower
Upper
pCL
CL Value
886.4 36311.36 0.0418*
2704.7
3508.8
13317.4
14121.4
16908.5

32720.26 0.0865
31916.23 0.1016
22107.63 0.5829
21303.60 0.6526
18516.53 0.9192

Oneway Analysis of Cell Number By Sample Type Time Point=120 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.30600

Alpha
0.05

Connecting Letters Report
Level
Negative Control

Mean
34230.000

A
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Level
Positive Control
HDR
LDR

Mean
27958.933
23135.067
13272.800

A B
B C
C

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

- Level Difference

Negative
Control
Positive
Control
Negative
Control
HDR
Negative
Control
Positive
Control

LDR

Std Err Lower CL
Upper
pDif
CL Value
20957.20 4552.929 10458.1 31456.27 0.0017*

LDR

14686.13 4552.929

4187.1 25185.21 0.0121*

HDR

11094.93 4552.929

595.9 21594.01 0.0408*

LDR
Positive
Control
HDR

9862.27 4552.929
6271.07 4552.929

-636.8 20361.34
-4228.0 16770.14

0.0622
0.2057

4823.87 4552.929

-5675.2 15322.94

0.3203

A.3. Aim 3: Normalized Growth Rate Stats
Oneway Analysis of Normalized Growth Rate By Sample Type Time Point=6
Hours
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Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
LDR
PC
HDR

Mean
1.2576871
1.0000000
0.9669632

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level
LDR HDR
LDR PC
PC
HDR

Difference
0.2907239
0.2576871
0.0330368

Std Err Dif
0.1494102
0.1494102
0.1494102

Lower CL
-0.074870
-0.107906
-0.332557

Upper CL p-Value
0.6563174 0.0996
0.6232806 0.1353
0.3986303 0.8323

Oneway Analysis of Normalized Growth Rate By Sample Type Time
Point=24 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05
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Connecting Letters Report
Level
LDR
PC
HDR

Mean
1.3700000
1.0000000
0.9500000

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level
LDR HDR
LDR PC
PC
HDR

Difference
0.4200000
0.3700000
0.0500000

Std Err Dif
0.4252058
0.4252058
0.4252058

Lower CL Upper CL p-Value
-0.620441 1.460441 0.3614
-0.670441 1.410441 0.4177
-0.990441 1.090441 0.9102

Oneway Analysis of Normalized Growth Rate By Sample Type Time
Point=72 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
HDR
PC
LDR

Mean
1.0326087
1.0000000
0.8500000

A
A
A
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Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level
HDR LDR
PC
LDR
HDR PC

Difference
0.1826087
0.1500000
0.0326087

Std Err Dif
0.3682457
0.3682457
0.3682457

Lower CL Upper CL p-Value
-0.718456 1.083674 0.6376
-0.751065 1.051065 0.6979
-0.868456 0.933674 0.9323

Oneway Analysis of Normalized Growth Rate By Sample Type Time
Point=120 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
LDR
HDR
PC

Mean
3.4939759
2.2650602
1.0000000

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
LDR PC
2.493976
2.559100 -3.76792 8.755867 0.3674
HDR PC
1.265060
2.559100 -4.99683 7.526952 0.6386
LDR HDR
1.228916
2.559100 -5.03298 7.490807 0.6481
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A.4. Aim 3: Cell Cycle By Day and Phase
Oneway Analysis of Percent Positive By Day Phase=G0/G1, Sample
Type=Control

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
3
2
1

Mean
68.056667
67.280000
65.970000

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
3
1
2.086667
2.601287 -4.27845 8.451788 0.4530
2
1
1.310000
2.601287 -5.05512 7.675121 0.6325
3
2
0.776667
2.601287 -5.58845 7.141788 0.7753
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Oneway Analysis of Percent Positive By Day Phase=G0/G1, Sample
Type=HDR

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
1
2
3

Mean
61.200000
59.276667
57.060000

A
A B
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
1
3
4.140000
1.165545
1.28801 6.991987 0.0120*
2
3
2.216667
1.165545 -0.63532 5.068654 0.1059
1
2
1.923333
1.165545 -0.92865 4.775320 0.1500
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Oneway Analysis of Percent Positive By Day Phase=G0/G1, Sample
Type=LDR

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.57058

Alpha
0.05

Connecting Letters Report
Level
1
2
3

Mean
67.396667
63.320000
61.460000

A
B
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
1
3
5.936667
1.003931
3.35598 8.517354 0.0020*
1
2
4.076667
0.897943
1.76843 6.384903 0.0062*
2
3
1.860000
1.003931 -0.72069 4.440687 0.1231

110

Oneway Analysis of Percent Positive By Day Phase=G2/M, Sample
Type=Control

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
2
3
1

Mean
26.743333
23.936667
17.973333

A
A
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
2
1
8.770000
2.431725
2.81978 14.72022 0.0113*
3
1
5.963333
2.431725
0.01312 11.91355 0.0496*
2
3
2.806667
2.431725 -3.14355
8.75688 0.2923
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Oneway Analysis of Percent Positive By Day Phase=G2/M, Sample
Type=HDR

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
2
3
1

Mean
34.873333
34.866667
28.703333

A
A
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
2
1
6.170000 0.9954229
3.73429 8.605712 0.0008*
3
1
6.163333 0.9954229
3.72762 8.599045 0.0008*
2
3
0.006667 0.9954229 -2.42905 2.442379 0.9949
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Oneway Analysis of Percent Positive By Day Phase=G2/M, Sample
Type=LDR

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.57058

Alpha
0.05

Connecting Letters Report
Level
2
3
1

Mean
32.816667
29.945000
24.440000

A
A
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
2
1
8.376667
1.444858
4.66254 12.09079 0.0022*
3
1
5.505000
1.615401
1.35248
9.65752 0.0191*
2
3
2.871667
1.615401 -1.28085
7.02419 0.1356
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Oneway Analysis of Percent Positive By Day Phase=S, Sample Type=Control

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
1
3
2

Mean
15.416667
7.980000
5.943333

A
B
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
1
2
9.473333
1.656614
5.41974 13.52692 0.0012*
1
3
7.436667
1.656614
3.38308 11.49026 0.0042*
3
2
2.036667
1.656614 -2.01692
6.09026 0.2649
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Oneway Analysis of Percent Positive By Day Phase=S, Sample Type=HDR

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
1
3
2

Mean
9.8533333
8.0000000
5.8366667

A
B
C

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
1
2
4.016667 0.3187708 3.236663 4.796671 <.0001*
3
2
2.163333 0.3187708 1.383329 2.943337 0.0005*
1
3
1.853333 0.3187708 1.073329 2.633337 0.0011*
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Oneway Analysis of Percent Positive By Day Phase=S, Sample Type=LDR

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.57058

Alpha
0.05

Connecting Letters Report
Level
3
1
2

Mean
8.5650000
7.9633333
3.7833333

A
A
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
3
2
4.781667
1.354018
1.30105 8.262280 0.0167*
1
2
4.180000
1.211070
1.06684 7.293155 0.0182*
3
1
0.601667
1.354018 -2.87895 4.082280 0.6754
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A.5. Aim 3: Cell Cycle By Sample Type and Day
Oneway Analysis of Percent Positive By Sample Type Day=1, Phase=G0/G1

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
LDR
Control
HDR

Mean
67.396667
65.970000
61.200000

A
A
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Difference Std Err Dif Lower CL Upper CL p-Value
Level
LDR
HDR
6.196667 1.277718
3.07020 9.323130 0.0029*
Control HDR
4.770000 1.277718
1.64354 7.896463 0.0097*
LDR
Control 1.426667 1.277718 -1.69980 4.553130 0.3069
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Oneway Analysis of Percent Positive By Sample Type Day=1, Phase=G2/M

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
HDR
LDR
Control

Mean
28.703333
24.440000
17.973333

A
A
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
HDR Control
10.73000
1.982415
5.87920 15.58080 0.0016*
LDR Control
6.46667
1.982415
1.61587 11.31746 0.0172*
HDR LDR
4.26333
1.982415 -0.58746
9.11413 0.0750
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Oneway Analysis of Percent Positive By Sample Type Day=1, Phase=S

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
HDR
LDR

Mean
15.416667
9.853333
7.963333

A
B
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control LDR
Control HDR
HDR
LDR

Difference Std Err Dif Lower CL Upper CL p-Value
7.453333
5.563333
1.890000

1.820299
1.820299
1.820299

2.99922
1.10922
-2.56411

11.90744 0.0064*
10.01744 0.0223*
6.34411 0.3392
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Oneway Analysis of Percent Positive By Sample Type Day=2, Phase=G0/G1

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
LDR
HDR

Mean
67.280000
63.320000
59.276667

A
A B
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control HDR
LDR
HDR
Control LDR

Difference Std Err Dif Lower CL Upper CL p-Value
8.003333
4.043333
3.960000

1.993943
1.993943
1.993943

3.12433
-0.83567
-0.91900

12.88234 0.0070*
8.92234 0.0889
8.83900 0.0942
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Oneway Analysis of Percent Positive By Sample Type Day=2, Phase=G2/M

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
HDR
LDR
Control

Mean
34.873333
32.816667
26.743333

A
A
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
HDR Control
8.130000
1.851510
3.59952 12.66048 0.0046*
LDR Control
6.073333
1.851510
1.54285 10.60381 0.0168*
HDR LDR
2.056667
1.851510 -2.47381
6.58715 0.3092
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Oneway Analysis of Percent Positive By Sample Type Day=2, Phase=S

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
HDR
LDR

Mean
5.9433333
5.8366667
3.7833333

A
A
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control LDR
HDR
LDR
Control HDR

Difference Std Err Dif Lower CL Upper CL p-Value
2.160000 0.3821285
2.053333 0.3821285
0.106667 0.3821285

1.22497
1.11830
-0.82837

3.095035 0.0013*
2.988368 0.0017*
1.041702 0.7895
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Oneway Analysis of Percent Positive By Sample Type Day=3, Phase=G0/G1

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.57058

Alpha
0.05

Connecting Letters Report
Level
Control
LDR
HDR

Mean
68.056667
61.460000
57.060000

A
B
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control HDR
Control LDR
LDR
HDR

Difference Std Err Dif Lower CL Upper CL p-Value
10.99667
6.59667
4.40000

1.956141
2.187032
2.187032

5.96825
0.97472
-1.22195

16.02509 0.0025*
12.21861 0.0295*
10.02195 0.1004
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Oneway Analysis of Percent Positive By Sample Type Day=3, Phase=G2/M

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.57058

Alpha
0.05

Connecting Letters Report
Level
HDR
LDR
Control

Mean
34.866667
29.945000
23.936667

A
B
C

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
HDR Control
10.93000
1.242148 7.736957 14.12304 0.0003*
LDR Control
6.00833
1.388763 2.438403
9.57826 0.0075*
HDR LDR
4.92167
1.388763 1.351737
8.49160 0.0165*
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Oneway Analysis of Percent Positive By Sample Type Day=3, Phase=S

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.57058

Alpha
0.05

Connecting Letters Report
Level
LDR
HDR
Control

Mean
8.5650000
8.0000000
7.9800000

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level
LDR Control
LDR HDR
HDR Control

Difference
0.5850000
0.5650000
0.0200000

Std Err Dif Lower CL Upper CL p-Value
0.9555496 -1.87132 3.041318 0.5672
0.9555496 -1.89132 3.021318 0.5800
0.8546695 -2.17700 2.216998 0.9822
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A.6. Aim 3: Apoptosis Stats
Oneway Analysis of Percent Positive By Sample Type State=Early Apoptotic,
Time=12 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
LDR
Control
HDR

Mean
29.516667
29.050000
24.183333

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Difference Std Err Dif Lower CL Upper CL p-Value
Level
LDR
HDR
5.333333 2.372957 -0.47308 11.13975 0.0657
Control HDR
4.866667 2.372957 -0.93975 10.67308 0.0861
LDR
Control 0.466667 2.372957 -5.33975
6.27308 0.8506
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Oneway Analysis of Percent Positive By Sample Type State=Early Apoptotic,
Time=Day 1

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
HDR
LDR
Control

Mean
25.683333
24.316667
23.666667

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
HDR Control
2.016667
1.558311 -1.79638 5.829716 0.2432
HDR LDR
1.366667
1.558311 -2.44638 5.179716 0.4142
LDR Control
0.650000
1.558311 -3.16305 4.463050 0.6911
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Oneway Analysis of Percent Positive By Sample Type State=Early Apoptotic,
Time=Day 2

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
HDR
LDR
Control

Mean
35.833333
33.000000
26.983333

A
A
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
HDR Control
8.850000
1.983777
3.99587 13.70413 0.0043*
LDR Control
6.016667
1.983777
1.16254 10.87079 0.0230*
HDR LDR
2.833333
1.983777 -2.02079
7.68746 0.2031
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Oneway Analysis of Percent Positive By Sample Type State=Early Apoptotic,
Time=Day 3

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
HDR
LDR

Mean
29.416667
28.600000
28.066667

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control LDR
Control HDR
HDR
LDR

Difference Std Err Dif Lower CL Upper CL p-Value
1.350000
0.816667
0.533333

1.862595
1.862595
1.862595

-3.20761
-3.74094
-4.02427

5.907605
5.374272
5.090939
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0.4959
0.6764
0.7842

Oneway Analysis of Percent Positive By Sample Type State=Healthy,
Time=12 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
LDR
HDR

Mean
13.183333
12.666667
10.133333

A
A
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control HDR
LDR
HDR
Control LDR

Difference Std Err Dif Lower CL Upper CL p-Value
3.050000 0.9663793
2.533333 0.9663793
0.516667 0.9663793

0.68536
0.16869
-1.84798

5.414645 0.0197*
4.897978 0.0395*
2.881312 0.6121
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Oneway Analysis of Percent Positive By Sample Type State=Healthy,
Time=Day 1

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
LDR
Control
HDR

Mean
20.400000
20.233333
20.150000

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
LDR
HDR
LDR
Control
Control HDR

Difference Std Err Dif Lower CL Upper CL p-Value
0.2500000
0.1666667
0.0833333

1.988904
1.988904
1.988904

-4.61667
-4.70001
-4.78334

5.116674
5.033340
4.950007
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0.9041
0.9359
0.9679

Oneway Analysis of Percent Positive By Sample Type State=Healthy,
Time=Day 2

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
LDR
HDR

Mean
27.966667
27.633333
27.283333

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control HDR
LDR
HDR
Control LDR

Difference Std Err Dif Lower CL Upper CL p-Value
0.6833333
0.3500000
0.3333333

1.687865
1.687865
1.687865

-3.44672
-3.78006
-3.79672

4.813391
4.480057
4.463391
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0.6996
0.8426
0.8500

Oneway Analysis of Percent Positive By Sample Type State=Healthy,
Time=Day 3

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
LDR
HDR
Control

Mean
33.833333
30.866667
29.250000

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
LDR Control
4.583333
3.483586 -3.94069 13.10736 0.2363
LDR HDR
2.966667
3.483586 -5.55736 11.49069 0.4271
HDR Control
1.616667
3.483586 -6.90736 10.14069 0.6589
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Oneway Analysis of Percent Positive By Sample Type State=Late Apoptotic,
Time=12 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
HDR
LDR
Control

Mean
14.250000
11.116667
10.283333

A
B
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
HDR Control
3.966667 0.6665278
2.33573 5.597601 0.0010*
HDR LDR
3.133333 0.6665278
1.50240 4.764268 0.0033*
LDR Control
0.833333 0.6665278 -0.79760 2.464268 0.2578
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Oneway Analysis of Percent Positive By Sample Type State=Late Apoptotic,
Time=Day 1

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
HDR
LDR

Mean
14.816667
13.466667
13.133333

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control LDR
Control HDR
HDR
LDR

Difference Std Err Dif Lower CL Upper CL p-Value
1.683333
1.350000
0.333333

1.214724
1.214724
1.214724

-1.28899
-1.62232
-2.63899

4.655657
4.322324
3.305657
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0.2151
0.3090
0.7930

Oneway Analysis of Percent Positive By Sample Type State=Late Apoptotic,
Time=Day 2

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
LDR
HDR

Mean
12.833333
10.933333
8.133333

A
A
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control HDR
LDR
HDR
Control LDR

Difference Std Err Dif Lower CL Upper CL p-Value
4.700000
2.800000
1.900000

1.005264
1.005264
1.005264

2.24021
0.34021
-0.55979

7.159792 0.0034*
5.259792 0.0318*
4.359792 0.1076
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Oneway Analysis of Percent Positive By Sample Type State=Late Apoptotic,
Time=Day 3

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
HDR
LDR
Control

Mean
12.633333
12.383333
11.033333

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level - Level Difference Std Err Dif Lower CL Upper CL p-Value
HDR Control
1.600000
1.333333 -1.66255 4.862549 0.2754
LDR Control
1.350000
1.333333 -1.91255 4.612549 0.3504
HDR LDR
0.250000
1.333333 -3.01255 3.512549 0.8574
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Oneway Analysis of Percent Positive By Sample Type State=Mid Apoptotic,
Time=12 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
HDR
Control
LDR

Mean
51.433333
47.483333
46.700000

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Difference Std Err Dif Lower CL Upper CL p-Value
Level
HDR
LDR
4.733333 2.788933 -2.09094 11.55761 0.1406
HDR
Control 3.950000 2.788933 -2.87427 10.77427 0.2064
Control LDR
0.783333 2.788933 -6.04094
7.60761 0.7882
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Oneway Analysis of Percent Positive By Sample Type State=Mid Apoptotic,
Time=Day 1

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
LDR
Control
HDR

Mean
42.150000
41.283333
40.700000

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Difference Std Err Dif Lower CL Upper CL p-Value
Level
LDR
HDR
1.450000 1.748227 -2.82776 5.727756 0.4386
LDR
Control 0.866667 1.748227 -3.41109 5.144423 0.6377
Control HDR
0.583333 1.748227 -3.69442 4.861090 0.7500
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Oneway Analysis of Percent Positive By Sample Type State=Mid Apoptotic,
Time=Day 2

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
HDR
LDR

Mean
32.216667
28.750000
28.433333

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control LDR
Control HDR
HDR
LDR

Difference Std Err Dif Lower CL Upper CL p-Value
3.783333
3.466667
0.316667

3.864343
3.864343
3.864343

-5.67237
-5.98904
-9.13904

13.23904
12.92237
9.77237
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0.3654
0.4042
0.9374

Oneway Analysis of Percent Positive By Sample Type State=Mid Apoptotic,
Time=Day 3

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
HDR
LDR

Mean
30.300000
27.900000
25.716667

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control LDR
Control HDR
HDR
LDR

Difference Std Err Dif Lower CL Upper CL p-Value
4.583333
2.400000
2.183333

4.286240
4.286240
4.286240

-5.90472
-8.08805
-8.30472

15.07138
12.88805
12.67138
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0.3260
0.5958
0.6287

A.7. Aim 3: PCR CD44 Normalized Stats
Oneway Analysis of CD44 By Sample Type Time Point=4 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
HDR
LDR

Mean
1.0167175
0.9607354
0.8483006

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control LDR
HDR
LDR
Control HDR

Difference Std Err Dif Lower CL Upper CL p-Value
0.1684169 0.1266661 -0.141524 0.4783576
0.1124348 0.1266661 -0.197506 0.4223755
0.0559821 0.1266661 -0.253959 0.3659228
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0.2320
0.4089
0.6740

Oneway Analysis of CD44 By Sample Type Time Point=24 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
HDR
Control
LDR

Mean
1.1153534
1.0019671
0.9972452

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
HDR
LDR
HDR
Control
Control LDR

Difference Std Err Dif Lower CL Upper CL p-Value
0.1181082 0.0860096 -0.092350 0.3285663
0.1133863 0.0860096 -0.097072 0.3238443
0.0047219 0.0860096 -0.205736 0.2151799
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0.2188
0.2355
0.9580

Oneway Analysis of CD44 By Sample Type Time Point=48 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
HDR
Control
LDR

Mean
1.1002635
1.0003304
0.9795728

A
B
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
HDR
LDR
HDR
Control
Control LDR

Difference Std Err Dif Lower CL Upper CL p-Value
0.1206907 0.0259646 0.057158 0.1842237 0.0035*
0.0999331 0.0259646 0.036400 0.1634661 0.0085*
0.0207576 0.0259646 -0.042775 0.0842906 0.4545
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Oneway Analysis of CD44 By Sample Type Time Point=72 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
HDR
Control
LDR

Mean
1.0336619
1.0000667
0.8977068

A
A B
B

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
HDR
LDR
Control LDR
HDR
Control

Difference Std Err Dif Lower CL Upper CL p-Value
0.1359551 0.0421102 0.032915 0.2389949 0.0179*
0.1023599 0.0421102 -0.000680 0.2053998 0.0511
0.0335952 0.0421102 -0.069445 0.1366350 0.4554
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A.8. Aim 3: PCR TP53 Normalized Stats
Oneway Analysis of TP53 By Sample Type Time Point=4 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
HDR
LDR

Mean
1.0560151
0.8409027
0.6671165

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control LDR
Control HDR
HDR
LDR

Difference Std Err Dif Lower CL Upper CL p-Value
0.3888986 0.2258365 -0.163703 0.9415005
0.2151124 0.2258365 -0.337490 0.7677143
0.1737862 0.2258365 -0.378816 0.7263881
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0.1358
0.3776
0.4708

Oneway Analysis of TP53 By Sample Type Time Point=24 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
HDR
LDR

Mean
1.0080213
0.8058629
0.7889076

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control LDR
Control HDR
HDR
LDR

Difference Std Err Dif Lower CL Upper CL p-Value
0.2191136 0.1148358 -0.061880 0.5001068
0.2021583 0.1148358 -0.078835 0.4831515
0.0169553 0.1148358 -0.264038 0.2979485
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0.1050
0.1288
0.8875

Oneway Analysis of TP53 By Sample Type Time Point=48 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
HDR
Control
LDR

Mean
1.1146671
1.0355265
0.8896036

A
A
A

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
HDR
LDR
Control LDR
HDR
Control

Difference Std Err Dif Lower CL Upper CL p-Value
0.2250635 0.1887999 -0.236913 0.6870403
0.1459229 0.1887999 -0.316054 0.6078997
0.0791406 0.1887999 -0.382836 0.5411174
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0.2782
0.4689
0.6897

Oneway Analysis of TP53 By Sample Type Time Point=72 Hours

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
2.44691

Alpha
0.05

Connecting Letters Report
Level
Control
HDR
LDR

Mean
1.0003198
0.8353338
0.6945519

A
B
C

Levels not connected by same letter are significantly different.

Ordered Differences Report
Level

Level
Control LDR
Control HDR
HDR
LDR

Difference Std Err Dif Lower CL Upper CL p-Value
0.3057680 0.0442653 0.1974548 0.4140812 0.0005*
0.1649861 0.0442653 0.0566729 0.2732993 0.0098*
0.1407819 0.0442653 0.0324687 0.2490951 0.0191*
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Appendix B
MatLab Scripts for Image Analysis

B.1. Separate_Tiff_Layers.m
path = 'C:/Users/tgharve/OneDrive/Research/Pictures for Matt/Wake
Forest 5-26-16/Control Day 1/';
%Adjust the loop conditions (range of p, image base) for each set of
images
for p = 21:25
base = strcat('p',num2str(p),'_thumb_w2Camera-TxRed');
basew = strcat('p',num2str(p),'_');
RGB = 0; %0 for RED filter, 1 for GREEN filter, 2 for BLUE filter
tiff_info = imfinfo(strcat(path,base,'.tif')); % return tiff
structure, one element per image
tiff_stack = imread(strcat(path,base,'.tif'), 1) ; % read in first
image
%concatenate each successive tiff to tiff_stack
for ii = 2 : size(tiff_info, 1)
temp_tiff = imread(strcat(path,base,'.tif'), ii);
tiff_stack = cat(3 , tiff_stack, temp_tiff);
end
[a b c] = size(tiff_stack);
if RGB == 0
image(:,:,1) = tiff_stack(:,:,1);
for i = 1:c/3-1
image(:,:,i+1) = tiff_stack(:,:,1+3*i);
end
elseif RGB == 1
image(:,:,1) = tiff_stack(:,:,2);
for i = 1:c/3-2
image(:,:,i+1) = tiff_stack(:,:,2+3*i);
end
elseif RGB == 2
image(:,:,1) = tiff_stack(:,:,3);
for i = 1:c/3-3
image(:,:,i+1) = tiff_stack(:,:,3+3*i);
end
end
[a b c] = size(image);
for j = 1:c
if j<=10
imwrite(image(:,:,j),strcat(path,'sep/',basew,'00',num2str(j1),'_ch',num2str(RGB),'.tif'));
elseif j > 10 && j < 100
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imwrite(image(:,:,j),strcat(path,'sep/',basew,'0',num2str(j1),'_ch',num2str(RGB),'.tif'));
else
imwrite(image(:,:,j),strcat(path,'sep/',basew,num2str(j1),'_ch',num2str(RGB),'.tif'));
end
end
end
%Repeat for the DAPI Channel
for p = 21:25
base = strcat('p',num2str(p),'_thumb_w1Camera-DAPI');
basew = strcat('p',num2str(p),'_');
RGB = 2; %0 for RED filter, 1 for GREEN filter, 2 for BLUE filter
tiff_info = imfinfo(strcat(path,base,'.tif')); % return tiff
structure, one element per image
tiff_stack = imread(strcat(path,base,'.tif'), 1) ; % read in first
image
%concatenate each successive tiff to tiff_stack
for ii = 2 : size(tiff_info, 1)
temp_tiff = imread(strcat(path,base,'.tif'), ii);
tiff_stack = cat(3 , tiff_stack, temp_tiff);
end
[a b c] = size(tiff_stack);
if RGB == 0
image(:,:,1) = tiff_stack(:,:,1);
for i = 1:c/3-1
image(:,:,i+1) = tiff_stack(:,:,1+3*i);
end
elseif RGB == 1
image(:,:,1) = tiff_stack(:,:,2);
for i = 1:c/3-2
image(:,:,i+1) = tiff_stack(:,:,2+3*i);
end
elseif RGB == 2
image(:,:,1) = tiff_stack(:,:,3);
for i = 1:c/3-3
image(:,:,i+1) = tiff_stack(:,:,3+3*i);
end
end
[a b c] = size(image);
for j = 1:c
if j<=10
imwrite(image(:,:,j),strcat(path,'sep/',basew,'00',num2str(j1),'_ch',num2str(RGB),'.tif'));
elseif j > 10 && j < 100
imwrite(image(:,:,j),strcat(path,'sep/',basew,'0',num2str(j1),'_ch',num2str(RGB),'.tif'));
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else
imwrite(image(:,:,j),strcat(path,'sep/',basew,num2str(j1),'_ch',num2str(RGB),'.tif'));
end
end
end

B.2. Compare_Expression.m
clear all;
th = 0.05; %threshold for conversion to black and white image (5% max
pixel intensity)
n=14; %number of z-planes in each image
%Do next for loop for each sample condition, i is the number of images
in each
%set (e.g. i=1:6 for p21 through p26). Change the path to the location
of
%each set of images
for i = 1:6
[cd1{1,i}, cd1_bw{1,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/Control Day
1/sep/p2',num2str(i),'_'),'_ch0.tif',n,th);
[cd1{2,i}, cd1_bw{2,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/Control Day
1/sep/p2',num2str(i),'_'),'_ch2.tif',n,th);
cd1_bw{2,i} = imfill(cd1_bw{2,i},'holes'); %fill holes in segmented
nuclei (DAPI Channel)
nuc(1,i) = mean(nonzeros(double(cd1_bw{2,i}).*double(cd1{1,i})));
%find mean intensity of TxRed Channel in segemented nuclei
cell(1,i) = mean(nonzeros(double(~cd1_bw{2,i}).*double(cd1{1,i})));
%find mean intensity of TxRed Channel everywhere else
end
for i = 1:5
[cd2{1,i}, cd2_bw{1,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/Control Day
2/sep/p2',num2str(i),'_'),'_ch0.tif',n,th);
[cd2{2,i}, cd2_bw{2,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/Control Day
2/sep/p2',num2str(i),'_'),'_ch2.tif',n,th);
cd2_bw{2,i} = imfill(cd2_bw{2,i},'holes');
nuc(2,i) = mean(nonzeros(double(cd2_bw{2,i}).*double(cd1{2,i})));
cell(2,i) = mean(nonzeros(double(~cd2_bw{2,i}).*double(cd2{1,i})));
end
for i = 1:5
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[cd3{1,i}, cd3_bw{1,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/Control Day
3/sep/p2',num2str(i),'_'),'_ch0.tif',n,th);
[cd3{2,i}, cd3_bw{2,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/Control Day
3/sep/p2',num2str(i),'_'),'_ch2.tif',n,th);
cd3_bw{2,i} = imfill(cd3_bw{2,i},'holes');
nuc(3,i) = mean(nonzeros(double(cd3_bw{2,i}).*double(cd3{1,i})));
cell(3,i) = mean(nonzeros(double(~cd3_bw{2,i}).*double(cd3{1,i})));
end
for i = 1:5
[hdr1{1,i}, hdr1_bw{1,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/HDR Day
1/sep/p2',num2str(i),'_'),'_ch0.tif',n,th);
[hdr1{2,i}, hdr1_bw{2,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/HDR Day
1/sep/p2',num2str(i),'_'),'_ch2.tif',n,th);
hdr1_bw{2,i} = imfill(hdr1_bw{2,i},'holes');
nuc(4,i) = mean(nonzeros(double(hdr1_bw{2,i}).*double(hdr1{1,i})));
cell(4,i) =
mean(nonzeros(double(~hdr1_bw{2,i}).*double(hdr1{1,i})));
end
for i = 1:5
[hdr2{1,i}, hdr2_bw{1,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/HDR Day
2/sep/p2',num2str(i),'_'),'_ch0.tif',n,th);
[hdr2{2,i}, hdr2_bw{2,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/HDR Day
2/sep/p2',num2str(i),'_'),'_ch2.tif',n,th);
hdr2_bw{2,i} = imfill(hdr2_bw{2,i},'holes');
nuc(5,i) = mean(nonzeros(double(hdr2_bw{2,i}).*double(hdr2{1,i})));
cell(5,i) =
mean(nonzeros(double(~hdr2_bw{2,i}).*double(hdr2{1,i})));
end
for i = 1:5
[hdr3{1,i}, hdr3_bw{1,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/HDR Day
3/sep/p2',num2str(i),'_'),'_ch0.tif',n,th);
[hdr3{2,i}, hdr3_bw{2,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/HDR Day
3/sep/p2',num2str(i),'_'),'_ch2.tif',n,th);
hdr3_bw{2,i} = imfill(hdr3_bw{2,i},'holes');
nuc(6,i) = mean(nonzeros(double(hdr3_bw{2,i}).*double(hdr3{1,i})));
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cell(6,i) =
mean(nonzeros(double(~hdr3_bw{2,i}).*double(hdr3{1,i})));
end
for i = 1:5
[ldr1{1,i}, ldr1_bw{1,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/LDR Day
1/sep/p2',num2str(i),'_'),'_ch0.tif',n,th);
[ldr1{2,i}, ldr1_bw{2,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/LDR Day
1/sep/p2',num2str(i),'_'),'_ch2.tif',n,th);
ldr1_bw{2,i} = imfill(ldr1_bw{2,i},'holes');
nuc(7,i) = mean(nonzeros(double(ldr1_bw{2,i}).*double(ldr1{1,i})));
cell(7,i) =
mean(nonzeros(double(~ldr1_bw{2,i}).*double(ldr1{1,i})));
end
for i = 1:5
[ldr2{1,i}, ldr2_bw{1,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/LDR Day
2/sep/p2',num2str(i),'_'),'_ch0.tif',n,th);
[ldr2{2,i}, ldr2_bw{2,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/LDR Day
2/sep/p2',num2str(i),'_'),'_ch2.tif',n,th);
ldr2_bw{2,i} = imfill(ldr2_bw{2,i},'holes');
nuc(8,i) = mean(nonzeros(double(ldr2_bw{2,i}).*double(ldr2{1,i})));
cell(8,i) =
mean(nonzeros(double(~ldr2_bw{2,i}).*double(ldr2{1,i})));
end
for i = 1:5
[ldr3{1,i}, ldr3_bw{1,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/LDR Day
3/sep/p2',num2str(i),'_'),'_ch0.tif',n,th);
[ldr3{2,i}, ldr3_bw{2,i}] =
Import_Confocal_Stack_sep(strcat('C:/Users/tgharve/OneDrive/Research/Pi
ctures for Matt/Wake Forest 5-26-16/LDR Day
3/sep/p2',num2str(i),'_'),'_ch2.tif',n,th);
ldr3_bw{2,i} = imfill(ldr3_bw{2,i},'holes');
nuc(9,i) = mean(nonzeros(double(ldr3_bw{2,i}).*double(ldr3{1,i})));
cell(9,i) =
mean(nonzeros(double(~ldr3_bw{2,i}).*double(ldr3{1,i})));
end
%Transpose the arrays for easier export to excel
cell = cell';
nuc = nuc';
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B.3. Import_Confocal_Stack_sep.m
function [A,B]= Import_Confocal_Stack_sep(froot,froot2,n,th)
if n>9
for k = 0:9
A(:,:,k+1) = imread(strcat(froot,'00',num2str(k),froot2));
B(:,:,k+1) = im2bw(A(:,:,k+1),th);
% ... Do something with image A ...
end
for k=10:n
A(:,:,k+1) = imread(strcat(froot,'0',num2str(k),froot2));
B(:,:,k+1) = im2bw(A(:,:,k+1),th);
end
else
for k = 0:n
A(:,:,k+1) = imread(strcat(froot,'00',num2str(k),froot2));
B(:,:,k+1) = im2bw(A(:,:,k+1),th);
end
end
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